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 SECTION A  
Response expectancies have been suggested to mediate hypnosis intervention outcomes. This 
review examined relevant studies to determine the quality of evidence for this proposed 
association. A systematic search produced ten studies that fulfilled inclusion criteria. The 
review provided some evidence for an association between response expectancy and 
mediation of hypnosis outcomes. However, study quality, generalisability and evidence for 
mediation were mixed. Further controlled trials of hypnosis-based interventions with varied 
clinical populations are needed to validate response expectancy as a mediator of hypnosis 
outcomes.  
SECTION B  
The methodological rigour of studies examining the effects of hypnosis upon migraines and 
tension-type headaches has been limited. This study developed and evaluated a single online- 
group session plus self-hypnosis intervention for this population. People with diagnoses of 
migraines or tension-type headaches (N = 35) participated in a pilot randomised controlled 
trial. The hypnosis group demonstrated significantly greater decreases in mean daily 
headache ratings and increases in medication-free days at four-week follow-up compared 
with waitlist-controls. Outcomes were not moderated by expectancy, attitudes to hypnosis, 
suggestibility or mediated by post-intervention changes in expectancy. Secondary 
improvements in depression, wellbeing, self-efficacy and internal-locus-of-control were not 
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Aim: Although hypnosis has an evidence base for providing improved outcomes across 
several health conditions, there remains debate over its defining characteristics and 
underlying mechanisms. Mediators are the constructs through which an intervention’s effects 
are funnelled to produce outcomes. Response expectancies have been proposed as mediators 
of hypnosis outcomes. Response expectancies are the anticipation of automatic, non-
volitional responses within specific contexts. There has not been a review of studies 
examining response expectancies as mediators of hypnosis-based outcomes. This review 
seeks to evaluate study findings and critique methodological quality. 
Methods: A systematic search of three electronic databases (Web of Science, PubMed and 
PsycINFO) identified ten studies examining response expectancies as mediators of hypnosis 
outcomes. These were synthesised and critiqued to provide an overview and implications of 
findings. 
Results: Response expectancies partially statistically-mediated hypnosis-based outcomes for 
experimental pain, post-surgical pain, fatigue, public speaking anxiety, but not hot flushes nor 
nausea. The evidence for causal mediation was less strong. 
Discussion: All studies were randomised controlled trials; however, most examined 
experimental pain, contained methodological weaknesses and poor reporting of demographic 
variables, therefore limiting generalisability. Replication with varied clinical populations is 
required to validate preliminary findings supporting response expectancy as a mediator of 
hypnosis-based outcomes. 







1.1 What is hypnosis? 
Despite hypnosis’ longstanding use as a therapeutic tool, its precise definition remains 
debated (Lynn et al., 2020). Hypnosis-type procedures used to treat individuals for various 
ailments via ceremonies that induced ‘trance-like’ states have been reported for centuries 
(Hammond, 2013). These ranged from shamanistic rituals to ancient Egyptian and Western 
religion-based healing procedures where direct commands for symptom relief were provided. 
These processes were crystallised and brought into broader societal awareness in the 1760s 
by Franz Mesmer’s mesmerism (Green et al., 2014).  
Mesmer proposed there was an invisible “animal-magnetism” force, which when 
individuals entered a trance, could be used to ameliorate various illnesses (Green et al., 
2014).  Although his contention of animal-magnetism as the mechanism of change was 
discredited, the outcomes of people getting better were not. It was considered improvements 
occurred due to people's beliefs the process relieved their symptoms (Hammond, 2013).  
Modern hypnosis is considered to have developed in the mid-1800s with the 
emergence of James Braid’s scientific-based conceptualisation of hypnosis as a process 
where suggestions are more readily received and responded to by participants during a 
process of ‘neuro-hypnotism,’ or quieting of the nervous system (Kittle & Spiegel, 2021).  
Using a parsimonious definition, hypnosis is a process that involves a person 
designated as the ‘hypnotiser’ who guides a motivated participant through a series of 
suggestions, to which the individual responds, and changes to imagined and experienced 
physical, perceptual and voluntary actions occur (Kihlstrom, 1985). This definition does not 




1.2 Hypnosis’ evidence base 
Considerable research supports hypnosis’ efficacy for symptom reduction across 
several conditions. Perhaps the strongest empirical support for hypnosis is for acute and 
chronic pain (Thompson et al., 2019). Montgomery et al.’s (2000) meta-analysis 
demonstrated a medium effect size (d=.67) for hypnosis-induced analgesia, with those 
receiving hypnosis on average achieving 75% greater pain decreases than no-treatment-
controls. Support for hypnosis’ beneficial effects extends to depression (Alladin, 2010; 
Milling et al., 2018), anxiety (Valentine et al., 2019), migraines (Milling, 2014), dental 
surgery (Patel et al., 2000), and weight-loss regimen adherence (Kirsch et al., 1995). 
Furthermore, when added to cognitive-behavioural therapy (CBT), hypnosis has 
demonstrated significantly improved outcomes over CBT for anxiety, insomnia, obesity and 
hypertension (Kirsch et al., 1995, Ramondo et al., 2021). Within the British National Health 
Service (NHS) hypnosis is a National Institute for Health and Clinical Excellence (2017) 
recommended treatment for irritable bowel syndrome.   
Despite this, hypnosis does not hold mainstream scientific and medical acceptance. 
This may reflect caricatured media portrayal, association with stage-hypnosis, and 
heterogeneity of research methodology and treatment protocols (Milling, 2014). Additionally, 
hypnosis has long been shrouded in mystery and mythological lore. This could be considered 
a strength for enhancing expectancy for ‘miraculous’ outcomes, but also a weakness due to 
‘fears of the unknown’ engendered within clinicians and the public alike (Lynn et al., 2020). 
1.3 Theories of hypnosis 
 Hypnosis’ theoretical underpinnings have historically been separated between state, 
and non-state (social-cognitive) theories (Jensen et al., 2015). The most significant debate has 
surrounded whether hypnosis is considered a unique cognitive state. This position is held 
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within state theories which maintain individuals enter a trance-state of altered-consciousness 
(Jensen et al., 2015). Neuroimaging studies however have not provided reliable findings to 
support this (Landry et al., 2017).   
Non-state theories refer to hypnosis as a construct of combined psychological and 
social factors. Hypothesised psychological factors include motivation (Lynn et al., 2019), 
expectancy (Kirsch, 1985), imaginal absorption (Nadon et al., 1991), placebo (Ploghaus et 
al., 2003), dissociation (Hilgard, 1992), compliance (Wagstaff, 1991) and attitudes to 
hypnosis and its perceived credibility (Spanos, 1986). Social-cognitive theories prioritise the 
importance of the hypnotic context and how the participant enacts socially constructed roles 
between the hypnotist and hypnotisee (Lynn et al., 2017). Spanos’ (1986) socio-cognitive 
role theory proposes thoughts, feelings and imaginings are transformed into behaviours 
believed consistent with what “one does,” during hypnosis. The social-psychobiological 
model (Jensen et al., 2015) stresses the influence of the hypnotist/participant relationship and 
emphasises the interaction of psycho-biological factors with personality characteristics to 
produce hypnosis (Jensen et al., 2015). However, the field lacks a definitive framework, and 
this has contributed to questions regarding the mechanisms that explain hypnosis’ effects.  
1.4 Response expectancies 
 Within the above theories a contended key ingredient is response expectancy. 
Response expectancy theory (Kirsch, 1985) maintains response expectancies are the 
anticipation of automatic, non-volitional responses following specific stimulus presentations 
or situational cues (Wickless & Kirsch, 1989). For example, expectation of increased 
alertness following caffeine consumption, will cause this to occur, even if the coffee is 
decaffeinated (Milling et al., 2002). Response expectancies can equally apply to sexual 
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function, situation-specific emotional responses, or the anticipation of automatic responses to 
varied medication or cancer-treatment protocols (Devlin et al., 2019). 
Following this theoretical-framework, hypnosis is hypothesised to achieve its effect 
via individuals’ heightened expectancy for nonvolitional responses following suggestion. 
Response expectancies are therefore self-generative processes that elicit automatic responses 
sufficient to create the consequent experiences (e.g. the thought of experiencing pain post-
surgery heightens pain response expectancy which translates to increased pain). Response 
expectancies differ from outcome expectancies which are premised upon how likely 
individuals believe outcomes will occur based upon voluntary or goal-directed behaviours 
(Cardena & Terhune, 2019). 
 Response expectancies have been implicated within psychotherapy (Weiberger & Eig, 
1999), placebo (Brody & Brody, 2000) and cancer treatment side-effect occurrence (Devlin et 
al., 2017). Sohl et al. (2009) demonstrated moderate associations between chemotherapy 
side-effect response expectancies and increased patient medication-related toxicities. Roscoe 
et al. (2004) evidenced individuals who rated “very likely” as opposed to “very unlikely” as 
their expectancy for chemotherapy side effects were five-times more likely to experience 
these. During initial placebo drug trials in the mid-20th century, it was observed that placebo 
drug effects depended on the individual’s beliefs about which drug they had consumed. 
Montgomery and Kirsch (1997) explored placebo analgesic treatment effects on pain and 
evidenced significant mediation by response expectancies. Lidstone et al. (2010) 
demonstrated that people with Parkinson’s Disease when given a placebo drug, experienced 
elevated endogenous dopamine levels by 75% and reduced symptoms. Subsequently, the 
placebo effect is associated with response expectancy.  
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 Response expectancies are hypothesised mediators of hypnosis outcomes due to the 
proposed contributions of placebo to the hypnotic process alongside heightened expectancy 
for automatic responses. It is considered once someone experiences hypnosis, they develop 
increased expectancy for non-volitional responses to occur (Sliwinski & Elkins, 2017). If this 
theory is correct, then response expectancy would be a meditator of hypnosis' outcomes. 
1.5 Mediation criteria 
Kazdin (2007) asserted that to understand how therapeutic intervention-based changes 
occur, mediation analysis is required. This assesses the indirect impact of a treatment on an 
outcome through a mediating variable. Baron and Kenny (1986) defined a mediator as a 
generative mechanism through which an independent variable (e.g. treatment) influences the 
dependent variable (e.g., outcome). Mediation represents hypothesised causality. 
Several methods of statistical mediation analysis exist. These range from hierarchical 
regression, to Baron and Kenny’s (1986) causal-steps model, which sequentially tests linear 
regression models for significance; to structural equation modelling, which facilitates 
concurrent investigation of indirect and direct relationships between constructs (Kline, 2011). 
Mackinnon et al. (2002) and Iacobucci et al. (2007) recommend bootstrapping (Preacher & 
Hayes, 2004) approaches over causal-steps and Sobel tests (Sobel, 1982) due to their 
increased statistical power. Despite this, the Baron and Kenny (1986) framework has been 
used most within mediation analyses. 
 Beyond statistical-mediation, Kazdin (2007) specifies additional criteria necessary to 
support mediation occurrence: ‘temporal-precedence’ requires changes demonstrated in the 
mediator prior to outcome-changes. This reduces the possibility the outcome created change 
in the mediator first. ‘Gradient’ refers to increased experience of intervention/dosages being 
associated with increased treatment outcomes (e.g. as session frequency designed to enhance 
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response expectancy increases, associated outcome improvements are observed). ‘Strong 
association’ asserts that demonstration of large effect size or high variance supports statistical 
mediation. ‘Consistency’ refers to stronger inferences about mediation being made if findings 
are replicated across similar studies and participants. ‘Specificity’ refers to increased 
mediation-likelihood if other constructs cannot potentially explain the mediation. 
‘Experimental manipulation’ refers to direct manipulation of the hypothesised mediator 
leading to direct outcome changes, which supports mediation. ‘Plausibility/coherence’ 
requires a credible theoretical account that fits with wider psychological understanding 
reasonable processes by which the mediator can be explained as the construct causing 
outcome change. Collectively, the demonstration of these factors, increases the likelihood of 
mediator presence.  
1.6 Review aims 
The present review is required as no previous reviews have examined the evidence for 
response expectancy in the mediation of hypnosis-based intervention outcomes. This 
narrative review aimed to conduct a systematic search of the literature examining hypnosis 
interventions that included a measure of response expectancy as a mediator of outcome.  The 
review sought to examine the evidence-base to highlight the potential value of response 
expectancy enhancement for increased therapeutic benefit from hypnosis interventions.   
2. Methods 
2.1. Literature search  
Searches were performed on 27/02/2021. Databases searched included Web of 
Science, Psychinfo and Pubmed, from response expectancy theory’s inception in 1985 to the 
date of the search. Search terms included: ("response expectancy" OR outcome expectancy 
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OR expectanc* OR “expected outcome”) AND (hypnosis OR hypnotherapy OR self-
hypnosis).  
Variations on the word expectancy were included to ensure relevant papers were not 
missed, as some authors used terms to mean slightly different things, but the focus was on 
response expectancy. Searches included relevant terms in “title,” “abstract” and “keyword”. 
Articles were first screened by title, abstract, and then full text. Reference sections of 
included studies were searched, and Google Scholar forwards and backwards searching was 
used to determine presence of additional relevant studies. 
2.2. Eligibility criteria  
The below inclusion criteria were utilised:  
1.  Studies were included if authors carried out a hypnosis-based intervention with pre and 
post measures of outcome for either an experimentally induced or clinical condition (e.g. 
pain). This included studies that incorporated hypnosis alone or hypnosis combined with 
CBT (where the separate effects of hypnosis could be examined). 
2. Response expectancy (the anticipation of automatic non-volitional responses (Kirsch, 
1985) was measured at pre- and post-intervention, and its relationship with intervention 
outcome was statistically examined. 
3. Because this literature is small, both clinical and non-clinical populations were included. 
4. The study was published in a peer-reviewed, English language journal.  
 The exclusion criteria below were utilised:  
1. Studies that solely utilised outcome measures of hypnotic-depth. This was because 
hypnotic-depth is not a treatment target (e.g. such as pain or anxiety-reduction). 
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2. Where there was no statistical analysis provided of the mediating role/contribution of 
response expectancy to the hypnosis intervention outcome. 




















Initial results n = 648 
Duplicates removed n = 82 
Excluded after title review n = 437 
Titles added after reference check from 
backwards search (no additional titles 
obtained from forwards search) n = 9 
Abstracts screened n = 138 
Excluded after abstract screen n = 82 
Full articles assessed for eligibility n = 56 
Excluded after full text screen n = 46: 
Mentioned expectancy unrelated to 
hypnosis 
Not primary research 
Response expectancy not assessed 
 
Final number of studies n = 10 
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Figure 1 illustrates articles found at each search-stage. Ten studies were identified. All were 
randomised controlled trials (RCTs).  
2.3. Quality assessment tool  
Study quality assessment followed the mediational study analysis applied by Gu et al. 
(2015). They adapted the  Jadad (Jadad et al., 1996) and CONSORT (Schulz et al., 2010) 
checklists, which evaluate RCTs, and combined these with some of Kazdin’s (2007) 
mediation criteria. Total study scores were calculated by assigning a value of 1 if met, 0.5 if 
partially met or 0 if not met to the 16 questions detailed in Table 2. Scores of 0–5 were 
categorised as low-quality studies with high-bias risk, 6–11 as medium-quality with 
moderate-bias risk and 12–16 high-quality with low-bias risk. These bandings are indicative 
only, and further detailed quality analysis is provided by study appraisal within the review 
and critique section. 
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N=83 (68% female) 
volunteer psychology 
students. Age and 




























with CBT on 
experimental pain: 
placing finger in 
pain stimulator 
machine for 60 
seconds.  
 











before experiencing a 
45-second glove pain-
relief suggestion. 
Participants then guided 
by presenter with pain 
relief suggestions 





measured on 11-point 
Visual Analogue 
Scale (VAS) anchored 
by ‘no pain at all’ (0) 
and ‘pain as intense as 
can imagine’ (10).  
Response expectancy 
Pain expectancy 
measured on same 
VAS scale except 
asked what they 
expected pain to be. 
Measured pre and 
post intervention. 
 
Primary findings: Hypnosis, HCBT 
(and CBT) reported greater pain 
reduction than controls. No intervention 
between group differences observed. 
Response expectancy: Decreases in 
pain associated with changes in pain 
expectancy reduction following 
hypnosis and HCBT conditions (but not 
CBT). Authors suggested 
response expectancies may perform a 
larger mediatory function in hypnosis 


















N=167 (63% female) 
volunteer psychology 
students. Age and 
ethnicity not stated 
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pool of 1100 students 
previously screened 
for suggestibility, 
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during pain stimulus. 
Primary: 
Pain intensity: 11-




measured on same 
VAS scale except 
asked what they 
expected pain to be. 




Primary: Changes in pain expectancy 
partially mediated effects of hypnosis, 
HCBT (and CBT and placebo) 
significantly greater than no treatment 
controls. All reduced pain intensity 
more than controls. Only CBT reduced 
pain more than placebo. Authors 
contended response expectancy may be 
greater for placebo. 
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by presenter with pain 
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measured on same 
VAS scale except 
asked what they 
expected pain to be. 





Primary: Hypnosis and Imaginative 
suggestion groups did not differ 
significantly from placebo in reducing 
pain, but all more effective than 
controls. 
Response expectancy: Hypnosis (and 
imaginative suggestion and placebo) 
pain reduction partially mediated by 
expectancy. Authors contended 
hypnosis and imaginative suggestions 
may be equally effective in lowering 
pain, and response expectancies are 
mechanisms of hypnotic, placebo and 
suggested pain reduction.  
Mediation analysis: 














N=188 (64% female). 
Mean age: 18.9 years 
(SD 3.31). Caucasian: 
64%, 14% African 
American: 14%, 5% 
Hispanic: 5%, Native 
American 4% Other: 
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second glove pain-relief 
suggestion. Participants 
then guided by 
presenter with pain 
relief suggestions 
during pain stimulus. 
Primary: Pain 
intensity: 11-point 
VAS scale (0-10). 
Response expectancy 
Pain expectancy 
measured on same 
VAS scale except 
asked what they 
expected pain to be. 
Measured pre and 
post intervention. 
 
Response expectancies partially 
mediated hypnosis and HCBT effects 
on pain outcomes (and CBT).  
Authors suggest results indicate 
response expectancies are central 
mechanism of hypnosis (and CBT) pain 
interventions  
 
Mediation analysis: Causal-steps  
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Primary: 
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point VAS scale (0-
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Pain expectancies (and credibility) 
mediated hypnosis (and CBT) 
independently. Mediation increased 
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Other: 0.8%, Not 
stated:13%. 
Recruitment: from 

























Participants then guided 
by presenter with pain 
relief suggestions 
during pain stimulus. 
Response expectancy 
Pain expectancy 
measured on same 
VAS scale except 
asked what they 
expected pain to be. 
Measured pre and 
post intervention. 
 
Authors contended treatment credibility 
also mediated hypnosis outcomes, in 
addition to response expectancies and 
are specific mechanisms of hypnosis 
and CBT pain treatments.  
Statistical analysis: 
Baron and Kenny causal-steps method 
followed by Sobel Test. 











N= 172 introductory 
psychology students 
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before experiencing a 
45-second glove pain-
relief suggestion. 
Participants then guided 
by presenter with pain 
relief suggestions 
during pain stimulus. 
Primary: 
Pain intensity: 11-





measured on same 
VAS as above except 
modified to ask what 
expected pain to be if 





Hypnosis, and placebo and imaginative 
suggestion all more effective than no-
treatment controls in experimental pain 
reductions. Hypnosis more effective 
than placebo. 
Response expectancy:  
All treatments partially mediated by 
pain expectancies: hypnosis (25%), 
imaginative suggestion (29%) and 
placebo (41%). Authors posited 
response expectancies a major 
mechanism of hypnosis and similalry in 
placebo and imaginative suggestion 
pain relief. 
Statistical analysis 
Causal-steps and Sobel Test used. 
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Explored effects of 
brief hypnosis on 
post-surgery pain 
and distress for 
breast biopsy 







minute induction of 
imagery for PMR; 
suggestions to imagine 





(e.g., you will feel 
comfortable, confident) 
Primary:  
Post-surgery pain and 
distress measured by 
10 cm VAS: "How 
emotionally upset are 
you feeling right 
now? And "How 
much pain do you feel 
right now? Anchored 
by ‘Not at all upset’ 
Primary: Post-surgery pain and 
distress reductions were significantly 
greater for the hypnosis group. 
Response expectancy as mediator 
Change in pain response expectancies 
post-hypnosis intervention partially 
mediated effects of hypnosis on pain 
outcomes. Effects of hypnosis on 
reducing post-surgery distress mediated 
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feel after the biopsy?  
 
Mediation statistical analysis 
Causal-steps 




















conservation surgery.  
Mean age: 48.50 
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15% Hispanic, 13% 
African American, 
9% Other, 13%  
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sample scheduled for 
breast conserving 
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Single session: A 15- 
minute relaxation-based 
induction, deepener, 
suggestions for pleasant 
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nausea and fatigue 
response expectancies 
captured using 10cm 
VAS scales. (e.g. 
VAS for expected 
pain asked, “After 
surgery, how much 
pain do you think you 
will feel? Anchored 
by “no pain at all” and 
“as much pain as 
there could be.” 
Scores ranged from 
0–100 based on mm 
from left side. 
Emotional distress 
assessed via anxiety 
subscale of Short 
Version of Profile of 




Primary (response expectancy):  
Pain expectancy partially mediated 
hypnosis’ effect on post-surgical pain 
(emotional distress did not). Nausea 
expectancy did not mediate post-
surgery nausea (but presurgical distress 
did). Fatigue expectancy partially 
mediated post-surgery fatigue (and by 
presurgical distress). 
Mediation analysis 
Separate models constructed for pain, 
nausea, fatigue. Each model tested 
mediation by the relevant expectancy 
for that outcome, and pre-surgical 
emotional distress. Statistical mediation 
assessed via calculating product of path 
coefficients which composed the 
indirect effect divided by the 
bootstrapped product standard error. 











N=95 (68% female) 
people with public 
speaking anxiety and 
determined clinically 
anxious (>19) on the 
Anxiety Expectancy 
(AE) scale taken from 
PRCS. Ages: 18-56. 
Mean age and 






Assessed if HCBT 







anxiety during a 
speech) and if this 
Group sessions: 5 x 2-




to enter hypnosis and 
CBT framework for 









(AE) scale. Asked to 
predict extent of 
anxiety during a 
speech, using 5-point 
Primary: Participants improved in both 
conditions compared with controls, 
however HCBT group had greater 
improved outcomes. 
Expectancy: HCBT generated greater 
change expectancies than CBT group. 
These correlated positively with 
improved treatment outcome.  
HCBT generated greater expected and 
decreased anxiety outcomes than CBT. 
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 Baseline differences 
on AE present.  
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hypnotic suggestions as 
opposed to automatic 
thoughts. CBT group 
received same sessions 
as HCBT, except term 
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Improvement in HCBT correlated with 
positive attitudes toward hypnosis. 
Anxiety expectancy scale, indicated 
participants in HCBT expected less 
anxiety following intervention than 
CBT group. 
Mediation analysis 
Correlational. ANCOVA to account for 
pre-treatment group differences on 
expected anxiety. 
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hypnosis over 5-week 
period. Each involved 
induction, suggestions 
for coolness, an 
imagined safe place and 
relaxation.  







via 10cm VAS pre 
and post intervention 
 
Secondary:  







Effects of hypnosis on hot flush 
frequency not mediated by response 
expectancy. Authors hypothesised  
response expectancy for hot flash relief 
may function differently for hot flashes 
than pain. 
Statistical analysis 
Ordinary least squares path analysis 
used to test 3 simple mediation models 
of indirect group effect on hot flushes 
via response expectancy change after 
first session. Bootstrap sampling used. 
 
Note: AE = Anxiety expectancy, ANCOVA= analysis of covariance, CBT = cognitive behavioural therapy, CURSS, PCRS= Personal Report of Confidence 
as a Speaker (Paul, 1966), HCBT = hypnosis combined with CBT, PMR= progressive muscle relaxation, RCT= Randomised Controlled Trial, SD= standard 








Table 2: Study quality checklist 


















et al. (2002) 
Montgomery 
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1) Was a theoretical framework 
cited?  
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
 
 
2) Was the mediator’s 
psychometric characteristics 
tested and within accepted 
ranges (e.g. Cronbach's alpha 
> .7)? 
 
No No No No No No No Partial Yes No 
3) Was the outcome variable’s 
psychometric characteristics 
tested and within accepted 
ranges (e.g. Cronbach's 
alpha> .7)? 
 
No No No No No No No No No No 
4) Was sample size determined 
from a power calculation and 
adequately powered to detect 
mediation? 
 
No No No No No No No Yes No Yes 
5) Was there an active control 
group? 
 
Yes Yes Yes Yes No Yes No Yes Yes Yes 
6) Was it a randomised study? 
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
7) Was randomisation method 
described and appropriate (e.g. 
random numbers table, 
computer-generated)? 
 
No No No No No No No Yes No Yes 
8) Were 
experimenters/participants blind 
to group assignment? 
 
No  No  No No No No No No No No 
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9) Was flow of participant 
information described (numbers 
assigned to groups, analysed 
and dropped out)? 
 
No No No No No  No  Yes Yes Yes Yes 
10) Were qualifications of 
facilitators reported? 
 
No No No No No No Partial Yes Yes Yes 
11) Did measurement of change 
in proposed mediator occur 
before outcome? 
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
12) Was change in proposed 
mediator used in mediation 
analysis measured during 
treatment? 
 
Yes Yes Yes Yes Yes Yes Yes Yes No No 
13) Was the proportion of 
intervention participants who 
received adequate dose of 
intervention reported? 
 
Yes Yes Yes  Yes Yes  Yes  Yes Yes Yes Yes 
14) Was mediation analysis 
carried out only with 
participants who received 
adequate intervention doses? 
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
15) Was post-intervention 
outcome controlled for baseline 
outcome?  
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
16) Was the statistical 
mediation analysis used the 
most appropriate? 
No Partial Partial Partial Partial Partial Partial Yes No Yes 




3. Review and critique   
All studies were RCTs and incorporated either a hypnosis or hypnosis plus CBT 
(HCBT) intervention for the purpose of alleviating specific symptoms (e.g., experimental or 
post-surgical pain or anxiety), and an examination of whether the outcomes were mediated by 
response expectancies (e.g. pain expectancy, fatigue expectancy). The studies can be 
separated into four examining clinical conditions (Montgomery et al., 2002, 2010; 
Schoenberger et al., 1997; Sliwinski & Elkins, 2017) and the remaining six, which assessed 
experimental pain within the laboratory environment.  
Because the clinical studies possess increased heterogeneity, these are given longer 
overviews to provide context of relative strengths and weaknesses, followed by briefer non-
clinical study descriptions due to their relative homogeneity. All studies are then synthesised 
collectively by methodological considerations: design, sample, intervention, outcome 
measures and mediation. This is to aid understanding of study variations that may have 
contributed to different mediation outcomes and the requirement for mediator presence to be 
determined from across collective study findings. See Table 1 for study-specific information 
and Table 2 for the quality appraisal checklist. 
Studies with clinical populations 
Montgomery et al. (2002) 
This study explored whether hypnosis was more effective than standard medical care 
in reducing post-surgical pain and distress for 20 females following excisional breast biopsy 
surgery; and whether the effects were mediated by post-hypnosis intervention changes in pain 
response expectancy, in addition to pre-surgical distress. The participants were recruited from 
a single American medical centre’s waitlist and were randomised to standard medical care or 
hypnosis groups. At baseline, measures in pain response expectancy and distress using a 10 
cm visual analogue scale (VAS) This ranged from 0: “no pain at all” to 10: “as much pain as 
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there could be,” and were taken prior to the single 15-minute hypnosis session administered 
prior to surgery. This consisted of induction, deepening, progressive muscle relaxation and 
suggestions for relaxation and to visualise a “special-place.” Additionally, provision of 
positive suggestions (e.g., ‘you will glow with health’) and negative suggestions (e.g., ‘you 
will feel less pain’) for pain relief were administered. Pain response expectancy and distress 
were measured immediately after the hypnosis intervention and pre-surgery. Post-surgery 
pain and distress reductions were significantly greater for the hypnosis than the standard 
medical care group. The hypnosis intervention effects on pain and distress were partially 
statistically mediated by post-hypnosis pain response expectancies, while post-surgery 
distress was also statistically mediated by postintervention expectation.  
Study strengths included measurement of post-intervention pain expectancy 
immediately after the hypnosis session, prior to surgery (temporal-precedence demonstrated) 
and clear sample-characteristics reporting, with ethnic composition broadly representative of 
the general American population. The study was limited by a small sample recruited from the 
same Texas medical practice, therefore limiting generalisability. Additionally, there was no 
active control group comparison, therefore limiting determination of hypnosis as the reason 
for observed outcome changes. The study scored eight, indicating moderate-bias risk. 
Montgomery et al. (2010) 
Montgomery et al. (2010) broadly replicated the above study design with several 
alterations made. In addition to pain response expectancy, they assessed the roles of post-
hypnosis nausea and fatigue expectancies, and pre-surgical distress in independently 
mediating post-tumour excision pain, nausea, fatigue and distress in females with breast 
cancer. A larger sample size of 200 was recruited and an active comparison group (structured 
counselling) was utilised, which controlled for hypnotherapist attention and time. The same 
hypnosis intervention was used as in the Montgomery et al. (2002) study. Response 
22 
 
expectancies (pain, nausea, fatigue) and distress were also assessed at baseline and post-
intervention prior to surgery, along with outcome measures using VAS scales. These showed 
postsurgical pain was partially mediated by pain response expectancy. Postsurgical nausea 
was not mediated by nausea response expectancy but partially mediated by presurgical 
distress. Post-surgery fatigue was partially mediated by fatigue response expectancy and 
presurgical distress. The authors hypothesised pain response expectancies may have differing 
mechanisms to nausea expectancies.  
Study strengths included its large sample size from a clinical population, 
representative ethnic diversity, and an intervention well controlled with temporal-precedence 
demonstrated and an active-comparison-group used. Improved statistical-mediation analysis 
was used that assessed independent contributions of response expectancies and distress 
within simultaneous regression models, and structural equation modelling and bootstrapping 
to increase power. Study limitations included reduced generalisability due to recruitment 
from a small geographical region and although this was one of the more methodologically 
rigorous studies, the regression models showed response expectancies still only accounted for 
30% of total variance of outcomes, however this was twice that of what pre-surgical distress 
predicted as a mediator. This study produced the highest methodological quality score with 
13.5 out of 16.  
Schoenberger et al. (1997) 
This study assessed whether a five-session group hypnosis plus CBT intervention 
alleviated public-speaking-anxiety more than CBT alone, while also assessing if outcomes 
were mediated by response expectancy (expected anxiety). The study sample was 95 people 
deemed to possess public speaking anxiety as operationalised by a score of 19 or above on 
the Personal Report of Confidence as a Speaker (PRCS) questionnaire. Participants were 
recruited from both community and university samples. Anxiety response expectancy was 
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measured at baseline as well as the primary outcome measure of subjective units of distress 
(SUDS) obtained from a four-minute impromptu speech performed to study administrators. 
Participants were randomised to hypnosis plus CBT, CBT or no treatment control groups. In 
the hypnotic CBT treatment (HCBT), participants received five two-hour sessions in a group 
format (2-4 members). The format was identical to the CBT format but consisted of 
relaxation labelled as hypnotic, followed by induction and suggestions to enter hypnosis. 
HCBT participants received the same CBT-based framework for social phobia, which 
included cognitive restructuring, exposure work, and progressive muscle relaxation, however, 
these were framed as hypnotic suggestions as opposed to automatic thoughts.) Anxiety 
response expectancy was re-measured immediately after the first intervention session. Upon 
treatment completion, a final four-minute speech was given, and SUDS recorded. Outcomes 
showed the HCBT group had greater anxiety reductions than CBT alone. The HCBT group 
generated greater reductions in anxiety expectancy than CBT and these change in 
expectancies were correlated positively with anxiety reduction as operationalised via SUDS 
for the final four-minute speech. Change in expected anxiety was the only predictor of 
improved outcomes.  
Study strengths included: mediation was measured before outcome to demonstrate 
temporal precedence and hypnosis was well controlled for with the comparison CBT group. 
The study was limited by poor sample demographics reporting and recruitment from an 
undergraduate and self-selected community sample making generalisability limited. 
Additionally, given sessions were delivered in group format over five-weeks, it is possible 
benefits were from group interaction as opposed to solely the hypnosis intervention. The use 
of SUDS to assess anxiety reduction potentially compromised internal validity due to 
increased subjectivity from this self-report measure. Furthermore, the use of correlational 
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methods to statistically assess mediation were less powerful than regression analysis. This 
produced a score of 10, representing moderate bias-risk. 
Sliwinski and Elkins (2017) 
This study explored whether changes in response expectancies post a five-session 
hypnosis intervention, mediated hot flush frequency outcomes in 172 post-menopausal 
women. Participants were randomised to hypnosis or active comparison control (structured 
attention counselling) groups. At baseline, measurements of hot flash expectancies measured 
via VAS were taken (as used within Montgomery et al., 2002; 2010). Participants received 
weekly individual hypnosis sessions over a five-week period which consisted of induction 
and suggestions for coolness, safe place visualisation, and relaxation. Participants also used 
self-hypnosis with a recording of the hypnosis session. Change in response expectancy was 
measured after the first intervention session. Outcomes demonstrated significantly reduced 
hot flush frequency for the hypnosis group, however findings did not support statistical 
mediation of reduced hot flush frequency by response expectancy. A study score of 12 was 
produced. 
Study strengths included the large sample size, good sample characteristic reporting 
and use of an active control comparison group. Powerful methods of statistical mediation 
analysis were used with ordinary least squares path analysis and bootstrapping techniques to 
increase power. A measure of effect size and follow-up at five-weeks were also incorporated.  
Response expectancy was measured at baseline and immediately post first intervention 
session to demonstrate temporal precedence.  
Limitations included poor detailing of the hypnosis intervention, administrator 
credentials and frequency of self-hypnosis use. This limits the extent of inference that can be 
made regarding why response expectancy mediation did not occur. Additionally, the sample 
was disproportionately white and non-representative of the general population.  
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In sum, the clinical studies demonstrated significant post-hypnosis outcome 
reductions of pain, nausea, public-speaking anxiety and hot flush frequency reductions. These 
were mediated by respective response expectancies for pain, fatigue and anxiety, but not for 
nausea or hot flushes. Findings were limited by sample representativeness and 
generalisability, but also raise the question whether there are differential mediatory 
mechanisms for hypnosis across pain, fatigue and anxiety versus hot flushes and nausea. 
Collectively they demonstrated temporal precedence and suggested statistical mediation, but 
it is worth recalling these are just two aspects of Kazdin’s (2007) mediation criteria. This will 
be considered in the discussion. The strongest studies methodologically were Montgomery et 
al. (2010), and Sliwinski and Elkins (2017), both deemed to be ‘high quality’, and lower 
scores were held by Schoenberger et al. (1997) and Montgomery et al. (2002), both 
‘moderate-bias’ risks. 
Non-clinical experimental pain studies 
The six remaining studies were highly similar in design and assessed non-clinical 
experimentally induced pain and included hypnosis interventions designed to reduce pain 
intensity outcomes. These studies were all based at the same north-eastern United States 
university, recruiting all participants from an undergraduate student population. All studies 
compared hypnosis with a variety of analogue interventions (e.g. CBT, non-hypnotic 
suggestion, distraction, placebo and control conditions). All experimentally induced pain and 
hypnosis intervention procedures were the same. These consisted of participants placing their 
index finger in an apparatus which administered mechanically induced pressure on the finger 
for a 60-second period. Baseline measures of pain intensity were recorded via the VAS to rate 
at 20 second intervals pain intensity out of ten. A total pain intensity score out of 30 was 
recorded. Participants were also asked to provide a pain expectancy rating using the VAS, 
pre-hypnosis intervention. All participants assigned to hypnosis interventions listened to a 
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recording of information to correct unhelpful beliefs about hypnosis, then underwent 
hypnotic induction from the Carleton University Responsiveness to Suggestibility Scale, 
(Spanos et al., 1983) then received information about hypnotic pain relief, received a 
hypnotic suggestion of 45-seconds to visualise a glove-like analgesia over the hand. After 
completion, a post-intervention pain expectancy rating was taken. The participant then 
repeated the same mechanically included pain procedure for another 60-second period. 
During the pain administration, the experimenter delivered the hypnotic glove analgesia 
suggestions in-vivo (while the participant remained in hypnosis). A final VAS outcome of 
pain intensity was then recorded. These procedures were replicated in all of the following 
studies with minor variations described by study below. 
Milling et al. (2002) 
This study examined 83 participants randomised to hypnosis, CBT or hypnosis-plus-
CBT (HCBT) intervention pain outcomes, while assessing the mediatory role of pain 
response expectancy. The hypnosis intervention was performed as above, while the CBT 
intervention consisted of progressive muscle relaxation, self-coping statements and use of 
guided imagery to be utilised during the pain administration. Reminders to implement these 
techniques during the pain administration were provided by the administrator. The HCBT 
condition relabelled self-coping strategies as hypnotic self-suggestions and progressive 
muscle relaxation as hypnotic relaxation. All groups reported significantly greater pain 
reduction than controls although no significant group differences were observed. Decreases in 
pain were associated with changes in pain expectancy reduction following the hypnosis and 
HCBT conditions, but not the CBT condition. Study strengths included the control afforded 
by the laboratory environment for precise between-group intervention comparisons and 
demonstration of temporal precedence of mediator change prior to change in outcomes. 
Weaknesses included a homogeneous university undergraduate sample with age and ethnicity 
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not reported, which limited generalisability. Additionally, hierarchical regression with 
reduced statistical power was used and non-clinical pain assessment limited real-world 
applicability.  
Milling and Breen (2003)  
 This study replicated the preceding experiment (with modification of comparison 
groups) and further assessed the mediatory function of response expectancies in hypnosis. A 
larger sample of 167 participants was randomised to either hypnosis, CBT, hypnosis plus 
CBT (HCBT), distraction, placebo or no-treatment control to assess differential response to 
pain. The hypnosis, CBT, HCBT interventions remained the same. The distraction group 
were trained to repeat monosyllabic words during pain presentation. The placebo group were 
given an inert topical solution from a bottle labelled ‘Trivaricaine’ and told it was a medical 
analgesic, before applied to the finger. Outcomes showed changes in pain response 
expectancy partially statistically-mediated the effects of hypnosis, HCBT (and CBT and 
placebo) more than no-treatment-controls. All interventions experienced reduced pain 
intensity more than controls. Relative strengths of this study were its larger sample size, 
carefully controlled comparison groups along with temporal precedence demonstration and 
the use of Causal-steps statistical mediation analysis (over hierarchical regression), but shared 
the previous study’s limitations of non-representative sample and limited generalisability of 
findings. 
Milling et al. (2005)  
This study explored whether hypnotic and nonhypnotic imaginative pain relief 
suggestions in comparison with placebo produced differential pain outcomes in 60 
participants, while assessing the mediatory role of pain response expectancy. The 
intervention groups were the same as described in the above studies, while the imaginative 
suggestion group was identical to hypnosis except it was framed as guided imagery without 
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the use of the term hypnosis. Hypnosis and the nonhypnotic suggestion groups did not differ 
significantly from placebo in reducing pain but were all more effective than no-treatment-
controls. The hypnosis intervention (and the non-hypnotic imaginative suggestion) pain 
reduction was partially mediated by pain response expectancy. The authors contended 
imaginative suggestions (nonhypnotic) may be as effective as hypnosis in reducing pain and 
that pain response expectancies may be shared mechanisms of placebo, hypnotic and 
suggested pain reduction. The study was constrained by lower powered hierarchical 
regression in addition to the previous studies’ limitations but also had a relatively lower 
sample making conclusions less reliable. 
Milling et al. (2006) 
 This study assessed whether hypnosis, HCBT, CBT, placebo or no-treatment control 
conditions differentially contributed to the experience of pain in 188 participants, while 
assessing the mediatory role of pain expectancy (replicating previous studies’ intervention 
protocols). Intervention effects on pain outcomes were all significantly greater than no-
treatment-controls (but non-significantly different to each other). Pain response expectancies 
again partially mediated treatment effects on pain outcomes in hypnosis (and CBT 
interventions). Similar study limitations were repeated (predominantly female sample), while 
strengths included better powered causal-steps mediation analysis, its much larger sample 
size and reported sample demographics, with ethnicity being broadly representative of the 
general American population, therefore increasing generalisability.  
Milling et al. (2007)  
This further assessed the role of pain expectancies in mediating pain outcomes and 
additionally assessed the potential mediatory role of treatment credibility. This was 
conducted with 123 participants for the differential impact of hypnosis, CBT or placebo 
reduction of pain. The study also explored whether mediation increases with greater 
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experience of further intervention sessions. Pain response expectancies and treatment 
credibility independently mediated hypnosis (and CBT) while as further repetition of the 
intervention occurred, so did further reductions in pain intensity. Study strengths included 
demonstration that mediation increased with increased intervention repetition. Additionally, 
increased rigour of statistical analysis was applied, with four simultaneous regressions using 
Baron and Kenny causal-steps method followed by Sobel Tests implemented. Like the 
previous study, demographics was reported in this study, therefore increasing findings 
generalisability. 
Milling (2009)  
This study assessed whether response expectancies were mediators of hypnotic 
suggested and placebo analgesia in 172 participants and incorporated a more detailed 
statistical mediation analysis by reporting the total variance percentages of mediation 
accounted for in the outcomes. Hypnosis, placebo and imaginative suggestion were all more 
effective than the no-treatment controls in reducing experimentally induced pain. Hypnosis 
was more effective than placebo. All interventions were partially statistically mediated by 
pain response expectancies: hypnosis (25%), imaginative suggestion (29%) and placebo 
(41%) conditions. Study strengths included its increased rigour of statistical mediation 
analysis and increased sample size which facilitated calculation of variances. Despite being 
reported in the two previous studies, age and ethnicity was not reported in this study therefore 
limiting generalisability of findings. 
 Collectively the non-clinical experimentally induced pain studies demonstrated 
hypnosis and HCBT interventions reduced laboratory-induced pain outcomes. Additionally, 
these effects appear to be partially statistically mediated by pain response expectancies. 
Strengths of these studies were the careful control of active comparison groups and that 
replication of study outcomes was found across several studies within close time-proximity of 
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each other. This satisfies Kazdin’s (2007) mediation criteria of ‘consistency.’ Additionally, 
these studies demonstrate temporal precedence of mediator change prior to outcome change. 
Utilising the study checklist criteria, all scored within the moderate risk of bias range. The 
studies also showed that mediation of pain outcome reductions by response expectancies may 
not be unique to hypnosis, but also shared by analogue interventions including CBT, placebo 
and non-hypnotic suggestions. Further evidence for mediation was supported in the Milling et 
al. (2007) study with increased experience of the intervention and mediator leading to 
increased pain outcome reductions. Weaknesses included the predominant non-reporting of 
sample characteristics. When it was, it was primarily a young undergraduate population and 
disproportionately female and all from the same university. Importantly, all studies examined 
mechanically induced pain within the laboratory environment, therefore greatly limiting 




 All studies benefited from random allocation and utilised a control-group comparison 
but were limited by lack of participant and experimenter blinding. Montgomery et al. (2002) 
randomised to standard-care or hypnosis. Montgomery et al. (2010) randomised and matched 
according to lumpectomy or excision surgery; while like Sliwinski and Elkins (2017), utilised 
an attentional control group. Schoenberger et al. (1997) randomised within stratified blocks 
so community and student participants were matched and utilised a waitlist-control group in 
their comparison of HCBT with CBT. All experimental pain studies matched groups for 
gender and suggestibility while comparing hypnosis with active-comparison groups. 
All study participants and experimenters were unable to be blinded to intervention due 
to hypnosis’ requirement to be named as part of hypnotic procedures. The experimental pain 
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studies blinded experimenters to participant suggestibility and participants were not informed 
experiments involved hypnosis until after baseline scores were taken. These participants were 
recruited from a pool of individuals previously screened for suggestibility. It was reported 
that to minimise connection between this and the experimental studies, activities were carried 
out in different locations by different therapists. However, this does not eliminate the 
possibility of anticipation of hypnosis and may have led to contamination-effects between 
conditions due to increased expectancy and therefore compromised subsequent statistical 
mediation analyses. While the experimental pain studies benefited from increased control of 
confounding variables within the laboratory environment, they were limited by non-reporting 
of randomisation-method, potentially compromising internal validity.  
Comparatively, for the clinical studies, the Montgomery et al. (2010) and Sliwinski 
and Elkins (2017) clinical study designs demonstrated the most methodological rigour with 
power calculations, computer-generated randomisation processes and reporting of study 
attrition rates and intention-to-treat analyses. Within the experimental-pain studies, while 
some pre-group differences were matched, and attrition rates appeared low, these findings 
were compromised as neither intention-to-treat-analyses were pre-specified, nor completion 
rates reported.  
3.2 Sample  
All studies took place in the United States with ages ranging from 17-61, and all 
comprised female majorities, ranging from 60.5-100%. Where reported, the majority 
ethnicity was “Caucasian” ranging from 50-69%. Sample characteristics were well reported 
in Montgomery et al. (2010) and Sliwinski and Elkins (2017) while ethnicity was not 
reported in Schoenberger et al. (1997), Milling et al. (2002), Milling and Breen (2003), 
Milling et al. (2005) and Milling (2009). Age ranges were infrequently reported in the 
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experimental studies; however, all were undergraduate students so it can be assumed they 
were disproportionately young.  
Participants were recruited from single medical surgeries (Montgomery at al., 2002, 
Montgomery et al., 2010), a large clinical trial (Sliwinski & Elkins, 2017) and mixed 
community and university samples (Schoenberger et al., 1997). The experimental pain studies 
recruited all participants from the same university. 
Minimal or no inclusion/exclusion criteria were applied to the non-clinical pain 
studies, while Montgomery et al. (2002), Montgomery et al. (2010) and Sliwinski et al. 
(2017) incorporated criteria specific to either hot flashes (e.g., requiring seven per day, not 
using hormone replacement therapy) or breast cancer (mastectomy or lumpectomy with full 
dissection). 
Collectively, the studies’ poor sample characteristics reporting restricts study 
generalisability to the United States, and white females. For the experimental pain studies, 
generalisability beyond healthy university students is limited and means there is reduced 
applicability to clinical acute and chronic pain conditions. Not only is pain context-specific 
but significantly milder and predictable within the laboratory environment (Edwards et al., 
2005).  
3.3 Intervention 
Hypnosis intervention varied considerably across studies and makes cross-study 
comparison difficult. The experimental pain studies and Montgomery et al. (2002) and 
Montgomery et al. (2010) were brief single sessions, while Schoenberger et al. (1997) and 
Sliwinski et al. (2017) were delivered weekly over five weeks. Additionally, Schoenberger et 
al. (1997) was HCBT, which was similarly used within several of the experimental pain 
studies. Schoenberger et al. (1997) delivered sessions within a group format. Additionally, 
intervention comparison is difficult when comparing conditions as diverse as hot flushes and 
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post-surgical pain and nausea. Hypnosis intervention detail was poorly reported in Sliwinski 
and Elkins (2017). Given no statistical mediation by hot-flush response expectancies was 
observed, it is unknown whether poor choice of non-automatic suggestions attuned to 
response expectancy were used and contributed to the non-significant statistical mediation. 
Subsequent determination of hypnosis intervention components that work best for who, is 
particularly difficult to establish across reviewed studies. 
3.4 Outcome measures 
Nearly all studies used 10 cm visual analogue scales (VAS) for outcomes except for 
Schoenberger et al. (1997) which used SUDS. The VAS scales incorporated a scale of 11 
numbers ranging from zero to ten and consisted of anchoring questions adapted to each 
intervention. As reflected in Table 2, Cronbach’s alpha was unable to be reported for these 
measures. 
Similarly, all the outcome measures were self-report. This opens the possibility for 
bias and demand characteristics and potentially compromises the internal validity of study 
findings. Only Schoenberger et al. (1997) included a validated questionnaire measure of 
anxiety, and Montgomery et al. (2010) a secondary measure of emotional distress (non- 
response expectancy) via the Short Version of the Profile of Mood States (SV-POMS) 
anxiety subscale. 
Measures of response expectancy between studies varied depending on outcomes 
assessed but were predominantly VAS scales. These ranged from pain, anxiety, fatigue, 
nausea to hot flush expectancy. This raises the question of how suitable this measure is for 
capturing more nebulous experiences such as hot flashes, and if more direct physiological 
measures would be better suited (e.g., blood pressure, cortisol). Bijur et al. (2001) however, 
report high reliability of the VAS for pain measurement, with 90 percent of ratings 
reproducible within 9 mm when assessing acute pain (Bijur et al., 2001). Devlin et al. (2019) 
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assessed the measure with a male population undergoing radiotherapy in comparing the VAS 
with five-point Likert scales assessing response expectancies. Findings showed that the VAS 
detected more response expectancies, as the midpoint of the Likert scale produced more 
uncertain answers (Devlin et al., (2019). 
3.5. Mediation analysis 
 Most studies used Baron and Kenny’s (1986) causal-steps regression method to assess 
if hypnosis-based interventions were statistically mediated by response expectancy. This 
involved assessment that the intervention produced change in the mediator, that the mediator 
was correlated with the outcome and that the mediator accounted for variance previously only 
associated with the intervention in univariate analysis. Implementation of this methodology 
varied slightly. Schoenberger et al. (1997) utilised a sub-optimal and depowered correlational 
measure of the post hypnosis change in expectancy with outcome. In the Milling et al. (2007) 
study, four simultaneous regressions equations were employed. Montgomery et al. (2010) 
utilised separate mediation models for each of pain, fatigue and nausea using structural 
equation modelling with Hayes’ (2004) bootstrapping methodology. They tested two 
mediators within each model: presurgical distress and relative measure of post hypnosis 
expectancy. Sliwinski and Elkins (2017) utilised ordinary least squares path analysis and 
Hayes’ (2004) bootstrapping methodology. 
 The use of Baron and Kenny’s (1986) method of causal-steps regression analysis has 
the significant limitation of being less powerful than subsequently developed statistical 
techniques. which may have limitations, particularly when working with smaller sample 
sizes, and the bootstrapping methodology as employed by Montgomery et al. (2010) and 
Sliwinski et al. (2017) may have been more appropriately applied. 
All studies measured response expectancy at baseline and immediately after 
intervention. This supports Kazdin’s criteria of temporal precedence, ensuring change in the 
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mediator occurred prior to change in the outcome. Multiple groups and conditions examined 
across these studies supports Kazdin’s idea of ‘Consistency’ with converging evidence from 
multiple sources to support the role of response expectancies as mediating pain, fatigue and 
anxiety. Additional support of Kazdin’s specification of ‘gradient’ demonstration was 
provided in Milling et al.’s (2007) study. This demonstrated that increased experience of the 
intervention dose, more change in the outcome was observed. Also, plausibility of response 
expectancy mediating outcome is provided given the extensive theoretical basis (e.g. Kirsch, 
1985, 1997) and the multiple studies within this review supporting this theory. 
Collectively, the weight of studies demonstrating this effect is of importance when 
reviewing the potential role of response expectancies as mediators of hypnosis-based 
intervention effects. The multiple findings across studies are supportive of the role played by 
response expectancies in mediating hypnosis outcomes, however, this may be limited to 
conditions of pain, and possibly fatigue and anxiety (given the non-significant findings for 
hot flushes and nausea).  
4.Discussion 
4.1 Summary 
All hypnosis interventions reported significantly greater pre-specified outcome 
reductions (pain, hot flash frequency, anxiety, nausea, fatigue) than comparison no-treatment-
control and attention control conditions. Consistent with response expectancy theory (Kirsch, 
1985), all reported partial statistical mediation of hypnosis outcomes by their respective 
response expectancies (pain, fatigue and anxiety) except Sliwinski and Elkins (2017) for hot 
flush expectancy. Montgomery et al., (2010) while finding fatigue and pain mediation by 
expectancy, did not observe this for nausea.  
Only two hypnosis studies demonstrated significantly greater post-intervention 
changes in response expectancy than CBT alone (Schoenberger et al., 1997; Milling et al., 
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2002). All remaining experimental pain studies observed non-significant differences between 
hypnosis and analogue pain treatments (CBT, placebo, imaginative suggestion, distraction) 
and increased post-intervention response expectancy changes.  
As discussed, according to Kazdin’s (2007) mediation criteria, this review has shown 
‘association’ has arguably been met due to demonstrated statistical mediation, ‘temporal 
precedence’ has been met due to experimental control and brief intervention designs 
facilitating this observation. ‘Consistency’ across studies was met, however this could have 
been improved with increased sample diversity. ‘Plausibility’ was also demonstrated across 
studies via their strong use of theoretical underpinning by response expectancy theory. 
Comparatively, ‘gradient’ and ‘experimental manipulation’ were less demonstrated. Although 
Milling (2007) demonstrated that increased experience of the intervention and mediator lead 
to increased pain reduction outcomes, response expectancy was not directly manipulated. 
Therefore, the reviewed studies broadly support the mediatory role of hypnosis by response 
expectancies for pain, fatigue and public-speaking anxiety, however, several limitations are 
applied to these findings.  
The findings are based on a relatively small number of studies and methodological 
questions were raised via the risk of bias tool, so results should be interpreted cautiously. 
This particularly applies to the non-clinical studies which all demonstrated medium risk-bias 
and limited external validity, raising the question whether similar findings would be observed 
in real-world settings. All studies relied heavily on subjective self-report measures, which 
may have led to shared variance (Podsakoff et al., 2003), and compromised internal validity. 
All studies were based in the United states, and most participants were University students. 
Additionally, the preponderance of relatively homogenous, white female populations further 
limits finding generalisability.  
4.2 Review limitations 
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 It should also be noted that demonstration of mediation is not definitive, and Kazdin’s 
(2007) multiple non-binary criteria reflects this. Therefore, the use of the study quality 
checklist holds these same limitations. This checklist may have also been more attuned to 
longer-term interventions (e.g., CBT/mindfulness delivered over 12 sessions) as reflected in 
some questions asked (e.g., “was adequate dose of intervention received”). Nonetheless, it 
functioned as an approximation of mediation/study-bias and broad categories of “medium” 
and “low” risk-bias were helpful to determine the more robust studies from which to draw 
conclusions regarding likely response expectancy mediation. Despite limitations, the 
checklist highlighted preliminary findings supportive of the mediatory role of response 
expectancies in hypnosis interventions. 
4.3 Theoretical implications 
Speaking broadly to hypnosis’ evidence base these findings are in line with 
Thompson et al.’s (2019) robust pain meta-analysis, with pain being perhaps the condition 
most strongly evidentially supported for hypnosis-influenced condition symptom reduction. 
The present review’s findings are aligned with this evidence, as the pain response was most 
consistently demonstrated to be mediated by pain response expectancies. 
Response expectancy theory is predicated upon expectation of automatic non-
volitional responses to specific situational contexts. Given that hot flushes and nausea are less 
predictable in their occurrence, the reduced temporal-contiguity between the intervention and 
potential symptom presentation may have contributed to the failure to find statistical 
mediation.   
Sohl et al.’s (2009) and Devlin et al.’s (2017) meta-analyses of cancer treatment side 
effects and response expectancies demonstrated larger effect sizes in studies where there was 
greater specificity between assessed outcomes and response expectancies. These studies 
methodologically incorporated likelihood of treatment related side-effects’ temporal and 
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geographical occurrence within designs. Although public-speaking anxiety may be a broad 
construct to define, this was very clearly linked in the Schoenberger at al. (1997) study to a 
specific task outcome and measure of anxiety response expectancy. This was reinforced by 
Montgomery et al.’s (2002; 2010) findings and the experimental pain study series which 
evidenced response expectancy statistical mediation and close temporal proximity between 
the intervention, and the outcome for which the hypnosis is intended to ameliorate and pain 
response expectancies mediate. Therefore, a common theme emerges of increased specificity 
of targeted event/outcome and immediacy of time contiguity between response expectancy 
measurement and targeted event of observed outcomes as important.  
 4.4 Research implications 
 Overall, the findings observed within this review, while broadly consistent with 
response expectancy theory and supportive of the mediatory role of response expectancies 
(particularly pain) in hypnosis interventions, speaks strongly to the requirement to validate 
the results with further research. A natural consequence from the above discussion would be 
to ensure future response expectancy mediatory research is enhanced by increased specificity 
and time contiguity between the response expectancy/mediator-influenced hypnosis 
intervention and specific proposed outcomes to fully capture and assess the mediatory effects. 
This would appear beneficial, given the benefit demonstrated by brief interventions such as 
single-session hypnosis prior to surgery which alleviated post-surgical pain and fatigue 
(Montgomery et al., 2002; 2010). This research seems vital in providing validation to a 
method that may provide considerable benefits to individuals undergoing surgery.  
Incorporating the mediatory role of response expectancies in influencing hypnosis’ 
outcomes, future research should ideally incorporate direct manipulation of response 
expectancies, however in practice, this is difficult to achieve. One possibility could be to 
experimentally manipulate expectancy via stating participants will receive hypnosis of 
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“greater strengths/intensity” and assess whether this increases response expectancy after this 
intervention and subsequently predict outcomes. Additionally, given emotional responses are 
implicated within response expectancies, the emotional-valent framing of information during 
informed consent processes could be a way of manipulating response expectancy to lead to 
improved outcomes (e.g., instead of specifying “60% likelihood of side effects, one could 
specify a 40% likelihood of highly positive outcomes”). Additionally, given that in the 
Milling et al. (2006) study, increased exposure to the intervention, lead to increased response 
expectancy changes it would be valuable to see if findings are replicated. Therefore, 
establishing studies which compare single versus multiple hypnosis sessions will be 
important in determination of optimal repetition of intervention to enhance response 
expectancy and therefore client outcome.  
 Further research with populations beyond predominantly white females will be 
important to establish whether benefits generalise to males, children, and non-white 
ethnicities. This is highlighted by Pieretti et al.’s findings supporting differential gender pain 
responses and Hoffman’s (2012) study finding females and younger age predicted greater 
response expectancies for cancer side-effects. Furthermore, it may well be that this previous 
research has inflated effect sizes for response expectancies within the present evidence-base 
due to relative sample female-homogeneity. Therefore, it will be important to recruit from 
non-female populations to see if the results are generalisable.  
4.5 Clinical implications 
While findings indicative of response expectancies mediating hypnosis-based 
interventions are only preliminary and tempered by methodological limitations, the findings 
highlight several potential areas of application (if validated with subsequent research). 
Given what has been demonstrated in the more rigorous clinical pain studies within 
surgical environments (e.g., Montgomery et al., 2010), findings are promising. The ability to 
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utilise a brief hypnosis intervention of 15-20 minutes to reduce pain and fatigue outcomes has 
immense significance for individual wellbeing and limited health service resources if people 
can leave hospitals sooner, post-surgery. Given that hypnosis is a procedure with few 
contraindications and safety risks (Häuser et al., 2016), this may be a simple and quick 
procedure to bring significant relief when factoring a risk benefit analysis of its 
implementation. If benefits have been observed in this environment, it is easy to conceive that 
these can be readily transferred to dental surgery or vaccine administration scenarios.  
Subsequently, if response expectancy is mediating these outcomes, then this raises the 
broader question of how clinicians can increase ‘buy-in’ with clients and heighten an 
individual’s response expectancy, optimism, and hope for improved outcomes. This could be 
achieved via direct experience of suggestion that enhances expectancy (e.g. hypnosis induced 
relaxation via suggestion that emphasises automatic and non-volitional outcomes).  
Interestingly, as highlighted within the experimental pain studies, hypnosis had 
comparable response expectancy mediatory and treatment outcomes to that of placebo and 
imaginative suggestions.  As discussed, the placebo effect suggests people align outcomes 
with their response expectancies, while even just using the term ‘placebo’ can improve 
outcomes. Carvalho et al. (2021) demonstrated significant pain reductions in individuals with 
back pain just by being told they were given placebo medication. Placebo administration of 
course has ethical problems, but hypnosis circumvents these issues by the intervention being 
presented as a transparent means of suggestion-provision that is likely to benefit the 
individual. Hypnosis ultimately provides the socially constructed ‘vehicle’ to ethically deliver 
a non-deceptive means for placebo-based suggestions which encourage hope and optimism 
for improved outcomes. Hypnosis provides a direct and immediate physical feedback 
response that offers a potential self-generative loop of experienced change that then leads to 
heightened response expectancies for improved outcomes. Further empirical demonstration of 
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hypnosis’ clinical utility may hopefully soon bring its benefits to increased clinician 
endorsement and ultimately wide transmission to clients who may benefit significantly. 
5. Conclusion 
 Consistent with response expectancy theory, response expectancies may mediate 
hypnosis interventions for specific conditions. This review highlighted mediation of 
conditions of pain, fatigue, and public-speaking anxiety, but not nausea or hot flushes. 
However, paucity of studies and present methodological limitations and measurement 
difficulties mean interpretations can only be cautionary. Therefore, more robust and 
statistically rigorous procedures that fully take into account Kazdin’s (2007) criteria are 
required to further research to validate with more diverse populations. If findings are 
replicated and validated then this may pave the way for simple, brief methods to rapidly 
enhance response expectancy for improved hypnosis outcomes and self-generatively lead to 
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Non-pharmacological interventions for migraines and tension-type headaches (TTHs) have a 
limited evidence base. Some evidence supports hypnosis as efficacious for alleviating 
migraine and TTH symptoms. These studies are predominantly over 25-years-old and have 
several methodological limitations. The present study assessed a single online group-
hypnosis session plus 14-days of self-hypnosis. Thirty-five people with migraine or TTH 
diagnoses (85.7% female) participated in a pilot randomised controlled trial, comparing 
hypnosis against waitlist-controls. Data analysis was performed with analysis of covariance 
(ANCOVA). The hypnosis group showed significantly decreased mean-daily headache 
ratings (d=.46, 95% CI -.30 to 1.21) and increased medication-free-days (d=.52, 95% CI -.24 
to 1.27) at four-week follow-up compared with waitlist-controls. Non-significant differences 
were observed across depression, wellbeing, internal-locus-of-control and self-efficacy 
measures, while trends towards decreased anxiety and migraine/TTH frequency for the 
hypnosis group were observed. Expectancy, treatment-credibility, and attitudes towards 
hypnosis did not moderate outcomes. Post-intervention expectancy changes did not mediate 
outcomes. Findings suggest migraine/TTH symptom reductions may be achieved at four-
week follow-up via a single online group hypnosis session plus 14-days of self-hypnosis. The 
predominantly white, female, and small sample size make conclusions regarding efficacy and 
generalisability limited. Obtained effect sizes may power a larger trial to explore promising 
preliminary findings. 






                                           1.Introduction 
Hypnosis is a process which involves a person designated as a hypnotist, guiding a 
motivated participant (who understands they are partaking in hypnosis) via suggestions to 
achieve imagined and actual physical, cognitive and perceptual changes (Kihlstrom, 1985). 
Considerable research supports hypnosis’ efficacy in reducing symptoms across numerous 
conditions. These include chronic and acute pain (Adachi et al., 2014, Montgomery et al., 
2000), anxiety (Valentine et al., 2019), depression (Milling et al., 2018) and post breast-
surgical pain and fatigue (Montgomery et al., 2010). Additionally, when combined with 
cognitive behavioural therapy (CBT), hypnosis has evidenced improved outcomes compared 
with CBT alone for depression and pain (Ramondo et al., 2021). It is also a National Institute 
for Clinical Health and Excellence (NICE) Guideline (2017) recommended treatment for 
irritable bowel syndrome (IBS).  Despite this, hypnosis has not achieved conventional 
medical acceptance and only holds complementary therapy status within the United 
Kingdom. This may reflect misconceptions due to stage hypnotism, incorrect media 
portrayal, and varied research and treatment protocol quality (Lynn et al., 2020).  
Theories and mechanisms of hypnosis  
 Debate surrounds theoretical explanations of hypnosis (Jensen et al., 2015). Differing 
positions have categorised hypnosis as either a unique ‘state’ or a conglomerate of 
psychosocial factors that produce favourable physical and cognitive outcomes. Neuroimaging 
studies provide insufficient evidence that hypnosis is a unique state, with few reliable patterns 
demonstrated (Landry et al., 2017). Proposed psychological factors include expectancy, 
motivation and attention (Kirsch, 1999), placebo, imagination, and attitudes towards hypnosis 
(Lynn et al., 2008). Environmental and social factors have also been hypothesised as 
important contributors. Spanos’ (1986) socio-cognitive role theory proposes individuals 
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transform thoughts and imaginings into behaviours believed consistent with how one 
“should” respond within hypnosis. Response expectancy theory (Kirsch, 1985) posits people 
experience what they expect to, in an automatic, non-volitional manner. This is predicated 
upon socio-culturally created expectations of what hypnosis “is” and “does.” 
More recent perspectives (e.g., Jensen et al., 2015) merge these positions and 
conceptualise hypnosis as an optimised ‘state’ of focused-attention and suggestion-
receptivity, entered via biopsychosocial factors. Given this process involves both cognitive 
and physical influences, this places hypnosis well to alleviate conditions like pain where 
significant physical and cognitive interactions occur (Shariff et al., 2009).  
Hypnosis and pain relief 
 The psychological behaviorism theory of pain and placebo (Staats et al., 2004) posits 
suggestion can ameliorate pain. Hypnosis utilises suggestion as a procedural cornerstone and 
has substantial support for pain-relief, with reviews summarising hypnosis’ efficacy across 
RCTs of chronic and acute pain conditions (Elkins et al., 2007; Jensen & Patterson, 2006).  
Thompson et al.’s (2019) meta-analysis of hypnosis for pain relief across 85 controlled-trials, 
demonstrated a medium effect size of between .54 to .76. Considering significant pain is 
generally experienced by people with migraine/TTHs, hypnosis would seem a natural 
application to these conditions (Ebied et al., 2020). 
Migraines and Tension-Type Headaches 
Migraines are complex neurological conditions affecting 15% of the general 
population and are the world’s third most prevalent disorder (Chaibi et al., 2011). The 
International Headache Society (IHS) defines migraines as “a common disabling headache 
disorder” lasting between 4-72 hours, predominantly unilateral, pulsating of moderate-severe 
intensity, exacerbated by normal activity and accompanied by nausea or light and sound 
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sensitivity. A minimum six headache-days per month, over a minimum 12-month period is 
required for diagnosis (IHS, 2013). Tension-type headaches (TTHs) are the most common 
headache, with 78% lifetime prevalence within the general population (IHS, 2013). They are 
distinguished from migraines by bilateral head pain, and absence of sensitivity to light/sounds 
(IHS, 2013). Migraines and TTHs produce multiple physical, cognitive, and emotional 
symptoms and sequalae (Buse et al., 2013). These can include intense pain, fatigue, impaired 
concentration, and an inability to engage in daily activities, work or socialise (Leonardi et al., 
2005). Both are associated with elevated comorbid depression and anxiety rates (NICE 
Guidelines, 2015).  
While migraine/TTH causes are complex and poorly understood (Goadsby, 2007), 
causal-factors are hypothesised to not only be genetic and neurological but maintained and 
exacerbated by psychosocial and environmental influences (e.g., thinking-styles, stress, 
socioeconomic-status) (Børte et al., 2019). Migraine/TTH pain can therefore be 
conceptualised as a multi-layered construct comprised of several biopsychosocial factors 
(Chapman, 2004). Over longer time-periods, these may exacerbate migraine/TTHs in 
‘vicious-cycles’ whereby individuals feel reduced hope for condition improvement (Børte et 
al., 2019). 
Hypnosis for migraines/TTH  
Several RCT’s have supported hypnosis’ efficacy in migraine/TTH symptom 
reduction when delivered face-to-face (Hammond, 2007). This includes hypnosis 
demonstrating reduced migraine/TTH frequency and intensity compared with waitlist-
controls (e.g. Friedman & Taub, 1984; Llaneza-Ramos, 1989, Melis et al., 1991), decreased 
frequency and severity compared with participants taking Stemetil medication (Anderson et 
al., 1975), reduced intensity compared with participants receiving autogenic training at six-
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months follow-up (Zitman et al., 1992), and equivalent decreased frequency with participants 
receiving biofeedback interventions (Andrechuk & Skriver, 1975).  
However, as reflected in the reviews of Hammond (2007), Milling, (2014) and Flynn, 
(2018), these studies are over 25-years old and have numerous methodological limitations. 
These include non-standardisation and detail of intervention, measures, and control. 
Additionally, poorly reported sample demographics and heterogeneous treatment-protocols 
have limited replicability (Milling, 2014). Collectively, these have hindered hypnosis’ 
endorsement as an effective migraine/TTH intervention (Lynn et al., 2020). Furthermore, this 
research has not fully explored hypnosis delivery-formats (Nicholson et al., 2005). Although 
hypnosis has traditionally been delivered one-to-one and face-to-face over several sessions, 
some studies have demonstrated delivery modifications that may widen treatment reach.  
Hypnosis delivery modifications and outcome predictors 
Gerson et al. (2013) assessed group-hypnosis for IBS and demonstrated significant 
symptom reductions at one-year follow-up. Spanos (1993) demonstrated equivalent outcomes 
for migraine experiencers from hypnosis delivered over one versus four sessions. Hasan et al. 
(2019) evidenced comparable IBS symptom reduction when delivered online or face-to-face. 
Flynn (2019) conducted an RCT for migraine experiencers which demonstrated significantly 
reduced durations for self-hypnosis participants compared with waitlist-controls. Therefore, 
combining hypnosis delivery-formats could be a means to increase treatment access.  
Additionally, determination of treatment-outcome predictors and the mechanisms of 
hypnosis are important to optimise therapy but have generally been overlooked in hypnosis 
research (Lynn et al., 2020). Exceptions have included: James et al. (1989) finding hypnosis 
influenced internal locus of control (ILOC), Holroyd et al. (2009) finding higher self-efficacy 
mediated improvements in a chronic-TTH population. Patterson and Jensen’s (2003) review 
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of hypnotic analgesia studies concluded participants higher in suggestibility demonstrated 
increased pain reductions, while Milling et al. (2007) evidenced positive attitudes towards 
hypnosis and treatment-credibility were correlated with greater pain reductions. Additionally, 
Kirsch’s (1985) response expectancy theory has demonstrated expectancy changes following 
hypnosis have mediated pain outcomes (Montgomery et al., 2010). These factors are 
therefore important to consider in hypnosis research-design optimisation. 
In summary, hypnosis research for migraines/TTH, has demonstrated promising 
outcomes, but is limited by study age and methodological concerns. There has since been 
varied delivery methods that increase treatment reach alongside several purported moderators 
and mediators of hypnosis outcomes suggesting further exploration. Additionally, given 
changes to NICE guidance for chronic pain (2021), recommending reduced long-term 
medication use due to deleterious health impact (alongside sub-group medication 
contraindications like pregnancy, heart-conditions), the further validation of a non-
medication-based intervention for migraines/TTH like hypnosis may be of heightened value. 
The present study  
This study was designed to explore whether a single hypnosis online group session 
plus 14-days of self-hypnosis could demonstrate improved migraine/TTH outcomes. While 
addressing previous hypnosis research limitations it is hoped to evidence a potentially 
standardised protocol for migraine/TTHs that might widen treatment reach and lower 
medication use. Considering limited NHS resources, a brief and cost-effective intervention 
predicated upon self-efficacy and ILOC that maximises treatment accessibility may be of 
benefit. This would help clinicians widen access, improve care and outcomes in line with 
client choice. In line with Medical Research Council guidance (Craig et al., 2008), this pilot 
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study also intends to provide estimated effect sizes for future larger-scale research. It is hoped 
this will help contribute to increased hypnosis research methodological rigour.  
 Based on the above literature, and in accordance with pre-study clinicaltrials.gov 
registration it was hypothesised that:  
1. As the primary measure, participants allocated to the hypnosis intervention group would 
show greater decreases in mean daily headache ratings compared to waitlist-controls 
following intervention at post-intervention. 
2. Participants allocated to the hypnosis intervention group would show greater decreases in 
headache frequency compared to waitlist-controls following intervention at post-
intervention. 
3. Participants allocated to the hypnosis intervention group would show greater decreases in 
related medication-use compared with waitlist-controls at post-intervention.    
4. Participants allocated to the hypnosis intervention group would show greater reductions 
in secondary outcomes of total Depression, Anxiety and Stress Scale (DASS), and 
depression and anxiety sub-scale scores compared to waitlist-controls. 
5. Participants allocated to the hypnosis intervention group would show greater increases in 
secondary measures of wellbeing, ILOC and self-efficacy compared to waitlist-controls 
following intervention. 
6. Reductions in mean daily headaches and their frequency, and all secondary measures 
would be maintained at four-week follow-up. 
7. Higher scores in treatment credibility, expectancy, attitudes towards hypnosis and 
suggestibility would moderate the above changes.  
8. Also, following completion of the Section A literature review but after trial registration, 
an additional hypothesis was developed. This was that changes in expectancy from 




2.1. Design  
The study used a pilot randomised control trial (RCT) to compare an intervention 
comprising a single online group hypnosis session plus 14-days of self-hypnosis, for adults 
with migraine or TTH, with a waitlist-control group. The single group plus self-hypnosis 
intervention was designed to maximise treatment reach. A one-off group session, followed by 
participants continuing the work at home on their own, resulted in the intervention being less 
dependent on therapist/resource availability that would have been required if delivered over 
several group sessions. 
Measures (questionnaires and headache diaries) were collected at three time-points: 
baseline (weeks 0-1), post-intervention (weeks 7-8) and follow-up (weeks 11-12). The 
waitlist-control group was offered the same intervention upon study completion. Feedback 
questionnaires were administered to the intervention group at study completion. Control 
group follow-up data was not collected because the study was designed as an RCT, therefore 
data was collected for the pre-specified experimental period only. 
Prior to commencement, study registration with an international register of trials kept 
by the United States Library of Medicine was completed (clinicaltrials.gov; registration 
number: NCT04523311; Appendix A). 
2.2. Participants and recruitment 
Participants were recruited via Facebook and Twitter. This included study 
advertisements posted by the National Migraine Centre, the Migraine Trust and two 
Facebook migraine support groups (Appendix B for advert and information-sheet). 




Table 1: Study inclusion and exclusion criteria  
Inclusion Exclusion 
Aged between 18-80 Current use of psychiatric medication 
Resident of the U.K. Diagnoses of epilepsy, psychosis, 
personality disorder, medication overuse 
headache 
Understand spoken and written English  
Self-reported diagnosis of migraine/TTH 
from GP or specialist (e.g. neurologist). 
 
Access to I.T. equipment   
Minimum 1 headache every 2-weeks over 




Otherwise healthy physically and mentally 
 
Scoring above cut-off scores on the HS-Q 




As seen in Table 1, the above criteria were applied for study inclusion. TTHs and 
migraines were both included as a pragmatic consideration to maximise recruitment. 
Additionally, previous psychological and hypnosis research (e.g., Martin et al., 2015; Spanos 
et al., 1993) has utilised this dual migraine and TTH diagnosis inclusion criteria. 
The exclusion criteria were established following the Guidelines for Trials of 
Behavioural Treatments for Recurrent Headache (Penzien et al. 2005). Additionally, due to 
ethical and risk considerations inherent in a new online trial, it was decided to begin with 
relatively tight inclusion criteria, so that a group of persons relatively less vulnerable to 
distress would be included. Therefore, to minimise these risks and ensure the wellbeing of 
participants, persons with diagnoses of personality disorder, epilepsy, psychosis, and people 
using psychiatric medication were excluded from participation.  
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The Headache Screening Questionnaire (HS-Q) (van der Meer et al., 2017) was used 
as a screening tool to ensure participants experienced migraine/TTH symptoms as reported 
(Appendix C). This is based upon IHS diagnostic criteria (IHS, 2013) and is recommended as 
the best single measure to identify TTH and migraines (van der Meer et al., 2019).  
Determination of study sample size was based upon Whitehead et al.’s (2016) 
assertion that a pilot study’s aims are more pragmatic, and a “rule-of-thumb” is recommended 
rather than a power calculation. Based upon Browne’s (1995) estimated 30 participants 
needed to approximate a parameter, and Julious’ (2005) recommended minimum 12 
participants per treatment-arm, a minimum sample size of 30 and maximum of 36 was sought 
and obtain 15 participants minimum per study-arm.  













Assessed for eligibility 
(n = 39) 
Excluded (n=4) 
Declared did not meet 
criteria (n=4) 
Randomised, 
(N = 35) 
Allocated to waitlist control (n=18) 
Withdrew without reason prior to 
intervention (n=1) 
Allocated to intervention (n =17) 
Received intervention (n= 15) 
Withdrew without reason (n=1) 
Withdrew due to childbirth (n =1) 
Analysed: 
Post intervention ITT analysis (n =15) 
Follow up ITT analysis (n=15*) 
*Missing data for headache diary (n=13) due 
to missing (n=2) participant diaries 
Analysed: 
Post intervention ITT analysis (n =17) 




Figure 1 shows 39 individuals were screened for eligibility and 35 randomised to group. 
Three participants withdrew after randomisation and 32 completed all questionnaires and 
headache diaries at post-intervention, while 30 completed all at follow-up.  












 Mean (SD) Mean (SD) Mean (SD)   






U = 142, z =  
-.363 
 
p = .717 
Gender      
Female 30 (85.7%) 14 16   




2 (5.7%) 1 1   
Diagnosis      
Migraine 14 (40%) 5 9   
Migraine with 
aura 
9 (25.7%) 7 2   
Chronic 
migraine 
7 (20%) 4 3   
Tension type 
headache 
2 (5.7%) 1 1   
Hemiplegic 
migraine 










17.01 (13.3) 14.70 (13.3) U = 134, Z =  
-.627 
p = .531 
Ethnicity      
White 32 (91.4%) 15 17   
Asian 1 (2.9%) 0 1   
Dual ethnicity 1 (2.9%) 1 0   
Other 1 (2.9%) 1 0   
Employment 
status 
     
Fulltime 14 (40%) 7 7   
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Part time 11 (31.4%) 5 6   
Self employed 5 (14.3%) 3 2   
Retired 2 (5.7%) 1 1   
Unemployed 2 (5.7%) 0 2   
Fulltime carer 1 (2.9%) 0 1   
 
Participant demographic data is presented in Table 2. Participant ages ranged from 
22–61 years (mean = 42.35 years). The majority were female (85.7%) and of white ethnicity 
(91.4%). The most frequent diagnosis was migraine (40%) followed by migraine with aura 
(25.7%) and chronic migraine (20%). Two participants had a TTH diagnosis (5.7%). The 
average time since diagnosis was 15.82 years. Fourteen participants (40%) were in fulltime 
employment, eleven (31.4%) part-time and five (14.3%) self-employed. No significant 
differences were observed between participants allocated to the intervention and control 
groups on demographic variables of age and time-since-diagnosis (p > .05). Due to the small 
sample and individual cell sizes of other demographic variables, Chi squared analyses for 
statistical differences were unable to be tested. 
2.3. Measures  
Measures (Appendix D) were all collected online via Qualtrics, while the 
migraine/TTH diary was collected via Excel spreadsheet. 
Migraine/TTH diary 
 Recorded hourly headache intensity ratings are considered the ‘gold standard’ in 
headache research (Andrasik et al., 2005). Therefore, mean daily headache was captured via 
an Excel spreadsheet that recorded hourly intensity ratings from 0-5 (0 = no headache, 5 = 
headache of maximum intensity) for each hour of the day. Headache intensity ratings were 
averaged to produce the mean daily headache rating over each two-week monitoring period. 
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Therefore, the primary outcome was a composite index which combined headache frequency, 
intensity and duration. Mean daily headache ratings were taken at baseline for two-weeks 
pre-intervention; two-weeks post-intervention; and two-weeks starting four-weeks post-
intervention completion, as a follow-up. Throughout this thesis, this is referred to as the mean 
daily headache rating and headache to refer to migraine/TTH incidence. It is acknowledged 
by the author that migraines and TTH are two separate conditions, and this is used for 
descriptive simplicity only. Total headache frequency was calculated by summing headache 
diary daily totals for each 14-day monitoring period. Measurement of medication usage was 
recorded as total number of medication-free-days recorded in the headache diary for each 
measurement period. Due to participant medication-type use variation between measurement 
periods, meaningful comparisons were not possible (17 participants altered medication-types 
used). Therefore, total number of medication-free days was used to measure changes between 
time-points. 
Depression, anxiety, and stress 
 To measure depression, anxiety and stress, the Depression Anxiety and Stress Scales 
(Short Form; DASS-21; Lovibond & Lovibond, 1995; Henry & Crawford, 2005) was 
utilised. This incorporates 21 questions (seven per depression, anxiety and stress scale) that 
measure depression (e.g. “I felt that I had nothing to look forward to”), anxiety (e.g. “ I found 
that I was using a lot of nervous energy”), and stress (e.g. “I found myself getting agitated”) 
over the previous week. These are scored from 0 (never) to 3 (almost always) and totalled to 
produce total individual scale scores. Scores are multiplied by two, to produce final scores 
(ranging between 0 and 42). Higher scores indicate increased distress. All scales demonstrate 
high internal consistency: depression (α= 0.88), anxiety (α = 0.82), stress (α= 0.90), and good 
convergent and discriminant validity (Henry & Crawford, 2005). Within the present study, 
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high internal consistency was shown for anxiety (α = 0.82), depression (α = 0.90), stress (α = 
0.86), and overall score (α = 0.94). 
Wellbeing 
 Wellbeing was measured via the Warwick-Edinburgh Mental Well-being Scale 
WEMBS (Tennant et al., 2007). This assesses psychological well-being over the previous 
two-week period. It consists of 14 items (e.g., “I have been feeling confident”), rated on a 
scale from 1 (none of the time) to 5 (all of the time). Individual scores are combined to 
produce total scores ranging from 14 to 70. Higher scores indicate increased well-being. The 
measure has good test-retest reliability, internal consistency, and discriminant and convergent 
validity (Tennant et al., 2007). Within the present study, the WEMBS internal consistency for 
total score was (α = 0.93). 
Internal-locus-of-control specific to headaches 
 Internal-locus-of-control (ILOC) specific to headaches was assessed via the ILOC 
subscale of the Headache specific Locus of Control Scale (HSLC). This is a validated 
measure (Martin et al., 1990) comprised of three subscales. Two are external-locus-of-control 
subscales: The Health Care Professionals subscale and the Chance subscale. The third is the 
ILOC subscale which has demonstrated good internal consistency (α = 0.88). This consists of 
11 items (e.g., “If I remember to relax, I can avoid some of my headaches”) rated from 
1(strongly disagree) to 5 (strongly agree). Within the present study, this subscale 
demonstrated good internal consistency of (α = 0.78). 
Self-efficacy specific to headaches 
Self-efficacy in relation to participants' beliefs they can manage their migraines/TTH 
was measured via The Headache Management Self-Efficacy Scale (HMSE). This is a 
validated and reliable measure with high internal consistency (α =.90) (French et al., 2000). 
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This consists of 25 items (e.g., “There are things I can do to reduce headache pain”) rated 
from 1 (strongly disagree) to 7 (strongly agree). Within the present study, the scale 
demonstrated good internal consistency of (α = 0.88). 
Moderators and mediators 
Treatment credibility and expectancy 
Beliefs about treatment-credibility and expectancy were assessed via The 
Credibility/Expectancy of Change Questionnaire (Devilly & Borkovec, 2000). This possesses 
a two-factor structure of perceived treatment credibility and expectancy for condition 
improvement (Thompson-Hollands et al., 2014). It is a reliable and valid measure with good 
internal consistency (credibility: α = .81 to .86; expectancy α = .83) (Devilly & Borkovec, 
2000). Expectancy is derived from item four: “by the end of the course, how much 
improvement in your functioning do you think will occur?” This is rated from 0 to 100%. 
Credibility is calculated from the total of the first three items to produce total treatment 
credibility (e.g., “At this point how logical does the course offered seem to you?” 0 = not at 
all, 9 = very). Within the present study, good internal consistency of (α = 0.84) was shown. 
Attitudes to hypnosis 
The Attitudes Toward Hypnosis and Hypnotherapy Scale (ATHHS) (Spanos et al., 
1987) is a 14-item, (e.g., “I am totally open to being hypnotised,” 1= not at all true, 7= very 
true), scale containing questions regarding fears, positive attitudes, and beliefs that 
susceptibility to being hypnotised is indicative of mental health difficulty. It has 
demonstrated good total score internal consistency of (α=.81) (Spanos et al., 1987). Within 
the present study, the total score demonstrated poor internal consistency of (α =.22). This will 




 A bespoke “experience of hypnosis” questionnaire was designed to capture 
suggestibility during the group-session. Due to group-session time constraints, a brief 
measure was derived from the standardised measure of the Harvard groups scale of hypnotic 
susceptibility, form A (Shor & Orne, 1962). Four suggestibility tasks were chosen based upon 
administration-ease and which captured different aspects of hypnotic suggestion. These were: 
eye closure (suggestion that one felt unable to open eyes once closed), hands clasped tight 
(suggestion that one unable to pull hands apart once hands clasped together), arm heaviness 
(suggestion that arm feeling heavier), and change in leg temperature (suggestion that leg 
alternating between cold and hot temperatures). Self-rated perceptions from 0-10 (0= no 
response, 10= maximum response) of how much participants felt they responded to each task 
were made. Within the present study, the scale demonstrated high internal consistency of (α 
=.88).  
2.3. Feedback questionnaire  
This was an eleven-item questionnaire designed to collect participant feedback on 
their study experience. Questions covered programme likes/dislikes, satisfaction, ease-of-use, 
potential improvements, how helpful hypnosis was experienced and how futures with 
migraines/TTHs were envisaged. Questions consisted of Likert scale items (e.g., “please rate 
how satisfied you were with the overall programme from 0: “not at all” to 10: “extremely;” 
and open-ended questions (e.g. “what did you like most about the programme and why”). 
This was administered at study-completion to the intervention group. 
2.4 Patient and Public Involvement and intervention development 
 The intervention was developed by the lead researcher. Initial consultation was held 
with a migraine-experiencer regarding the wording and suitability of the hypnosis script and 
group PowerPoint content. Additionally, following the 39 screening videocalls with 
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migraine/TTH experiencers, a high level of distress due to the severity and chronicity of 
migraine/TTHs was heard. It was also apparent, the extent that many felt disempowered, held 
reduced hope, and felt entrenched within what some perceived to be an at times ‘unhelpful’ 
medicalised health system. This was often reported because of experiences of visiting 
multiple specialists over many years, being prescribed several medications with perceived 
minimal changes to symptoms. Therefore, revisions were made to the group session 
presentation and hypnosis script that emphasised self-expertise and empowerment (whilst 
encouraged to work within the medical system). These were ratified in amendments to the 
study Ethics approval (Appendix E). 
2.5 Procedure 
 From study-advertisements, individuals were invited to contact the lead-researcher to 
discuss study eligibility via videocall. During the call, diagnosis confirmation was obtained, 
requests to view diagnosis letters made, eligibility questions asked, and the HS-Q completed. 
Those who met criteria provided online consent via Qualtrics. Individuals were informed they 
would be on a waitlist until numbers had been recruited to fulfil the first cohort (N=18).  
Once this was reached, participants were emailed to complete baseline questionnaires 
and the headache diary. Upon completion, diaries were checked to ensure at least one 
migraine was registered. Participants were randomised to group via a blocked 1:1 design 
method, using a computerised random generator (sealedenvelope.com). The same process 
occurred with the second cohort once the fulfilment number (N=17) was reached (two-days 
after first cohort establishment).  
Participants randomised to the hypnosis group were emailed confirmation of the 
group-session date. To aid familiarity, the day before the session, a two-minute video 
modelling the hypnosis induction was emailed to intervention participants along with the 
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session PowerPoint slides (Appendix F). Participants were asked to prepare two scenarios: 
their most typical situation within which migraine/TTH triggers occurred, and what their 
‘preferred-future’ looked like if increased control of migraines/TTHs was gained. Participants 
were asked to visualise these in vivid detail. 
 The video group-session was subsequently held. The first-cohort intervention group 
session contained eight participants, and the second-cohort, seven. These were held two-days 
apart. The group was led by the primary researcher (a qualified hypnotherapist and trainee 
clinical psychologist) who was joined by a project supervisor (a qualified clinical 
psychologist and hypnotherapist). Their role was to support anyone who experienced distress, 
in a breakout-room.  
The session contained introductions, confidentiality-discussions, information about 
hypnosis and its common misconceptions (to foster positive attitudes towards hypnosis). 
Hypnosis’ theoretical underpinnings, evidence base, and hypothesised psycho-social factors 
that contribute to migraines/TTHs were presented. General lifestyle factors and 
migraine/TTH triggers were discussed with participant self-expertise and knowledge 
emphasised. Theories of pain, placebo, expectancy, self-efficacy and ILOC were provided to 
increase expectancy for the positive impact of hypnosis on migraines/TTH symptom 
reduction. 
A 15-minute hypnosis ‘taster’ session was held (Appendix G). Its rationale was 
predicated upon response expectancy theory (Kirsch, 1985) which maintains prior 
intervention experience enhances expectancy for improved outcomes. The administrator 
modelled the induction and invited questions regarding what hypnosis would ‘feel or look 
like,’ to clarify uncertainties that may have interfered with hypnosis. The ‘taster’ session 
consisted of induction, suggestions for relaxation and being a good responder to hypnosis and 
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administration of the suggestibility tasks, before guided to emerge from hypnosis. 
Suggestibility ratings were recorded and feedback on individual experiences sought. 
A five-minute comfort break was held before the 20-minute hypnosis session for 
migraines/TTH (Appendix H). This consisted of induction, suggestions, visualisation of how 
one responds to triggers and what preferred futures with increased control over 
migraines/TTH looked like. Suggestions emphasised self-expertise, empowerment, self-
efficacy, ILOC, expectancy for improvement of self-control over migraine/TTH symptoms, 
and the additive benefit of daily self-hypnosis. 
Debriefing was held before self-hypnosis instructions were provided including 
instruction to listen at times that best suited people over the next 14-days. Participants were 
emailed the self-hypnosis recording and informed they would be contacted by the researcher 
in the next two-days to answer any queries.  
2.6 Hypnosis intervention 
The main hypnosis script was informed by the induction of Kirsch et al. (1993), 
followed by bespoke suggestions for relaxation. Based on Jensen and Patterson’s (2008) 
contention that chronic-pain suggestions should address the complexity of psychosocial 
factors associated with conditions of longer chronicity, these addressed symptoms in two 
ways. The first acknowledged broad lifestyle factors that contribute to stress. Therefore, 
suggestions were given to pace activity in non “all-or-nothing” fashion, communicate 
assertively with family members and work colleagues, exercise and eat in balanced manners 
and adopt kinder self-talk during difficulties.  
Secondly, suggestions were provided to address early warning signs and responses to 
migraine/TTH triggers. These were predicated on enhancing ILOC and self-efficacy (e.g. 
“every day I now feel more relaxed, strong, confident, more capable to take charge and 
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control over pain and discomfort in my life”). As summarised in Table 3, visualisation 
techniques were utilised, and participants were asked to imagine turning into miniature 
versions of themselves and travel to the source of discomfort in their body and push 
constricted blood vessels apart to bring relief to the source of pain. Participants were asked to 
visualise their early warning signs of migraines/TTH emerging and utilise this principle. 
They were encouraged to adopt externalising principles and imagine they can control and 
shrink headaches by following this procedure. They were asked to visualise their preferred 
future where they experienced increased control of migraines/TTHs. Additionally, the script 
included post-hypnotic suggestions to clench one’s hand when triggers emerged and 
implement this procedure. Further positive suggestions (e.g., you will feel healthy, 
comfortable, confident) and negative suggestions (e.g., you feel very little stress, pain) were 
incorporated. The effects were suggested to occur during, and after the group session, and be 
enhanced for every day of self-hypnosis completed. Following Kirsch et al. (1995), 
permissive suggestions tailored to automatic, non-volitional responses to enhance response-
expectancy were included. Traditional direct pain-relief suggestions (e.g., the affected body 
part becomes de-tensed with the arrival of a cooling sensation) were also included. 
Table 3: Intervention summary 
Intervention aspect Rationale 
Deconstruct misconceptions of hypnosis Foster positive attitudes to hypnosis 
 
Psychoeducation about general lifestyle 
factors that may contribute to 
migraines/TTHs 
 
Enhance individual self-expertise of awareness 
of own migraine/TTH triggers 
Psychoeducation on hypnosis’s efficacy 
for pain conditions and migraines/TTH’s 
Foster expectancy for deriving benefit form 
hypnosis 
  
Taster hypnosis session Enhance response expectancy for positive 
outcome via direct experience of physiological 
changes within hypnosis e.g. relaxation, 
apparent automatic body movements 
 
Main migraine/TTH group session  
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Provide suggestions of coping with life, 
people, job, friends with more confidence 
so that can take control over general 
lifestyle factors that may contribute to 
stress and triggers of migraines/TTH 
 
Externalisation of migraines/TTHs 
Develop self-efficacy, belief, confidence in 




Suggestions of given tool to shrink 
migraine (visualising shrinking self to 
miniature size and pushing apart 
constricted blood vessels inside one’s 
own body) 
 
Migraines/TTH something the individual can 
take control over (problem not located within 




Imagination/visualisation Imagined direct experience of taking increased 
control over migraines/TTHs and experience 
of a future where migraines/TTH are around 
less. Act as if changes already occurred. 
 
14-days of home self-hypnosis Enhance ILOC, self-efficacy, self-
empowerment via creating habit and change by 
self 
 
2.7 Ethical considerations  
Study ethical approval was provided by the Salomons Ethics panel, Canterbury Christ 
Church University. Additionally, the British Psychological Society’s (2014) Code of Human 
Research Ethics was followed. Several participant-safety discussions were held with a 
consultant neuropsychiatrist. From these conversations it was deemed negligible predictable 
risks to participants with migraines/TTHs were likely, however the study was in line with 
similar established protocols and was supported by the systematic review of Hauser et al. 
(2019) which concluded hypnosis to be a safe procedure with minimal risks. Nevertheless, 
participants were encouraged to contact GP or emergency services should they feel distress 
following self-hypnosis and were asked to email the lead-researcher should any questions or 
uncertainties arise. 
2.8 Analysis plan  
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 Statistical analysis of outcome measures was conducted using SPSS version 24. An 
intention-to-treat analysis was applied whereby all participants were analysed according to 
their allocated group at randomisation, irrespective of whether they completed the 
intervention. Analysis of covariance (ANCOVA) was used to examine between-group 
differences. The independent variable was group (wait-list control versus hypnosis). 
ANCOVA was chosen due to its increased power to detect between-group differences 
compared to ANOVA, as it avoids post-hoc comparisons, therefore reducing Type II error 
risk. The covariate was the baseline score on the respective outcome measures, and the 
dependent variable was the outcome measure at respective time-points (i.e., post-intervention 
or follow-up). There was a different ANCOVA for each primary and secondary outcome 
measure at post-intervention (Appendix J) and four-week follow-up (Appendix K).  
 Given there were some violations of normality, significant ANCOVA findings were 
checked by using the more robust Mann-Whitney U test to compare the two groups’ change 
scores from baseline to respective timepoints. In all cases, these supported ANCOVA 
findings, suggesting the normality violations were not problematic. Effect sizes were 
calculated utilising Cohen’s d statistic and confidence intervals (95%) were reported. 
Additionally, because this was a pilot study, and not fully powered to detect effects, trends 
were reported within the results section. 
 Moderation and mediation hypotheses were tested using Hayes (2013) bootstrapping 
technique, utilised via the PROCESS macro for SPSS (Appendix L). The bootstrapping 
method was chosen due to its increased statistical power through use of random re-sampling 
methods (Hayes, 2013). 
2.9 Qualitative feedback analysis 
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 Quantitative data from the feedback questionnaire questions were averaged and 
reported for the first four items. The seven open-ended questions were explored using content 
analysis. Categories were established and frequencies tabulated. Reliability was assessed via 
inter-rater agreement, with 25% of participants randomly sampled for dual rating.   
3. Results 
3.1 Baseline data  
 Baseline data for outcome measures across all time-points is presented in Table 6. No 
significant between group differences were observed between the hypnosis intervention and 
waitlist-controls across all baseline outcome measures (p > .05). Collectively, this suggests 
effective randomisation (Appendix I). Baseline scores on the DASS indicated the sample 
scored within the mild to moderate ranges of respective total and subscale measures, except 
for the wait-list control group who scored in the non-clinical band for anxiety (this remained 
non-significantly different to the intervention group score). 
3.2 Attrition and missing data 
Three of the 35 randomised participants withdrew from the study prior to 
intervention. These participants (11.7%) did not complete post-intervention or four-week 
follow-up measures. Two participants completed all measures at post-intervention and 
follow-up, but not the headache diary at four-week follow-up. As this was a pilot study with 
small participation numbers, the attrition numbers were too small to complete a statistical 
analysis to compare those who left the study with those who remained. The two participants 
with missing data at follow-up were excluded for analysis at follow-up time point only for 
mean headache scores, headache frequency and medication use. Their scores on all other 
measures were included. 
3.3 Intervention effects  
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 Intervention effects are visually depicted in Figure 2 and descriptive statistics are 
provided within Table 6 for all outcomes at all time-points. The primary outcome was mean 
daily headache rating. As can be seen from Table 7, no significant group differences at post-
intervention were observed for any measures. However, as shown in Figure 2, the primary 
outcome of mean daily headache rating showed a trend in favour of the hypnosis group at 
post-intervention. Furthermore, this became significant at follow-up, with a significant effect 
of intervention on mean daily headache rating, controlling for baseline mean daily headache 
rating (F (1, 29) = 4.53, p = .043). This was supported by the non-parametric Mann Whitney 
U test finding of a significantly greater decrease in mean daily headache rating for the 
hypnosis group than waitlist controls (U = 61.00, Z = -2.07, p = .038).  This test was used due 
to the deviations from normality, and as a follow-up to ensure findings were consistent with 
the significant ANCOVA findings. The effect size for the between group difference at 
follow-up was in the medium range (d=.46). 
 Similarly, as see in Table 7, there was a non-significant difference in total number of 
non-medication use days at post-intervention, but this became significant at follow-up, with a 
significant effect of intervention on total number of non-medication use days, controlling for 
baseline non-medication use days (F (1, 29) = 5.20, p = .032). This was supported by the non-
parametric Mann Whitney U test finding of a significantly greater decrease in total non-
medication use days for the hypnosis group than waitlist controls (U = 46.00, Z = -2.80, p = 
.005). The effect size for the between-group difference at follow-up was in the medium range 
(d=.52).  
 As can be seen from Table 7, there were no other significant differences between the 
intervention group and waitlist-control group at post-intervention and at four-week follow up. 
However, as this was a pilot study, it was not fully powered, so these may represent Type II 
errors. It is worth noting that as observed in Figure 2 there were non-significant trends 
77 
 
approaching significance in favour of the hypnosis group at follow-up for decreased 
migraine/TTH frequency (p=.056) and DASS anxiety score (p=.088). This was reflected in 
the mean anxiety score shifting from the clinical to non-significant range for the hypnosis 
group. Regarding clinical significance for headache activity, Blanchard and Schwarz (1988) 
specify a 50% or more reduction in headache activity, without associated increase in 
medication use functions as a marker of clinical significance. Within this study, seven out of 
17 of the hypnosis group compared with four out of 18 of the waitlist-control group met these 
criteria.  
3.4 Mediators  
 A mediation analysis was performed to examine if changes in expectancy statistically-
mediated the intervention effect on mean daily headaches. This was calculated at the follow-
up time-point to allow temporal precedence between proposed mediator and outcome. The 
change in mediator was measured from baseline to post-intervention and the primary 
outcome was measured at follow-up, with baseline levels of the primary outcome measure 
controlled for. As can be seen from Table 4, the hypothesised mediator did not have 
significant indirect effects, meaning there was no evidence for mediation. 
Table 4: Total, direct and indirect effects for bootstrapped-mediation-analysis, with group 
(hypnosis vs. control) the independent variable, mean daily headache rating at follow-up the 
dependent variable, mean daily headache rating at baseline the co-variate, and change in 
expectancy from baseline to post-intervention as proposed mediator. 
 Effect 95% CI 
Total effect 0.2356       (0.0085, 0.4626) *       
Direct effect 0.2342       (-0.0011, 0.4695)       
Indirect 
(mediation) effect 





 Similarly, as seen in Table 5, there was no significant moderation of the treatment 
effect by baseline expectancy, attitudes to hypnosis, treatment credibility or suggestibility. 
This is perhaps unsurprising, given that in the main analysis, they did not significantly change 
between assessed time-points (see Table 7). 
Table 5: Bootstrapped moderation analyses, with each row representing a separate analysis. 
The R2 change, F and p values refer to the change in model fit when a 'moderator X group' 
interaction term was added to the regression model. In all cases, the dependent variable was 
mean daily headache rating at follow-up and additional predictors were group (hypnosis vs. 
control), baseline mean daily headache rating, and the moderator. 
Moderator R2 change F (1, 25) p value 








.0171      1.6139       .2156 
 
A different analysis was conducted to examine suggestibility as these ratings were 
only taken for the hypnosis group. In this regression analysis, at the first step, baseline mean 
daily headache ratings were the predictor, follow-up mean daily ratings, the dependent 
variable and in the second step, suggestibility was added as an additional predictor. The 
additional predictor did not increase the explained variance (r2 change = .383, F=1.722 p= 
.220). Therefore, there was no evidence high suggestibility levels predicted outcomes, 
however, given the small sample size, it is possible this is a type II error. 
3.6 Participant Safety 
 Thirty four out of 35 participants reported no adverse experiences. One participant in 
the control group during hypnosis (after the trial-end), reported racing thoughts. This 
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appeared to be temporary and was managed by the second group-facilitator. The participant 


















































































































































































































































































































































*= p<.05  
^ = The effect sizes are Cohen’s d for the group differences at the respective time-points and do not control for baseline levels. 
 













P value Effect size^ (95% C.I.) 
Mean daily 
headache (/5) 
F (1, 29) = 1.306 .262 .35  
(-.38,1.07) 
 





F (1, 29) = 1.052 .314 .32 
(-.41, 1.04) 






F (1, 29) = 2.973 .105 .39  
(-.33, 1.12) 





F (1, 29) =1.999 .168 .12 
 (-.6, .85) 





F (1, 29) = .099 .755 .08  
(-.64, .81) 




F (1,29) = .950 
 
.338 .15  
(-.58, .87) 














F (1,29) = .020 
 
.889 -.19  
(-.91, .53) 
F (1,29) = .003 .954 -.01  
(-.73, .72) 
 
Internal Locus of 
control  
F (1,29) = .001 .970 -.06  
(-.78, .66) 





















 Of the 17 participants allocated to the hypnosis group, 12 (70.6%) completed the 
feedback questionnaire. The open-ended questions are summarised in Table 8, describing the 
content analysis.  The quantitative questions were on a 10-point scale from 1 (not at all) to 10 
(extremely) and answers were averaged.  Broadly, respondents were satisfied with the 
intervention with a mean rating of 8.2/10, experienced it easy to use (8/10) and found 
hypnosis moderately helpful (6.3/10). Adherence to self-hypnosis was high with an average 
12.4 out of 14-days completed. 
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Table 8: Content analysis categories and frequencies generated from open-ended feedback questions 




What did you like least about 
the programme and why 
Nothing identified 6  ‘nothing’ 
 
 Questionnaire and diary completion 5  ‘filling in the survey and spreadsheets but it's essential - hard 
sometimes with a bad head’ 
 
 Minimal change in symptoms 1  
 
‘migraines did not decrease’ 
What did you like most 
about the programme and 
why 
   
 Relaxing/ 
soothing 
3  ‘It was very relaxing’ 
 Programme administrator 2 ‘Administrator was very helpful and patient’ 
 
 Giving time to self 2 ‘Having 20 mins each day to relax and focus felt a positive 
approach to my migraines’ 
 
 Gaining a tool 2 ‘Another tool to help with migraine’ 
 
 Group session 1 ‘I liked the initial group session.’ 
 
 Self-hypnosis 1 ‘Following the self-hypnosis each day’ 
 Ease of use 1 
 
‘Ease of use’ 
Was there anything that was 
a barrier to using the 
programme? 
   
 Nothing identified 8 ‘No’ 
 
 Work 2 ‘Work was incredibly busy, and it was also around Christmas 




 Kids, busy home life 1 ‘No - only kids in the house - so weekends were hard/when I had 
a migraine’ 
 
 Ongoing health difficulties 1 ‘Ongoing health issues’ 
 
 Making time/prioritising 2 
 
‘I didn't prioritise it and also didn't have it saved somewhere 
convenient to access.’ 
Was there anything that 
helped you to continue using 
the programme? 
   
 Desire for change and self-time 1 desire for change and having time to myself 
 
 Positive impact it had on thinking 1 ‘The positive impact it had on my thoughts and attitude towards 
controlling migraines.’ 
 
 Check-ins from administrator 1 ‘Regular check ins and reminders’ 
 
 Self determination 2 ‘Just determination to continue doing it - so grateful for anything 
that reduces or improves migraine.’ 
 
 Having self- hypnosis stored on phone 2 ‘Having the recording on phone’ 
 
 Potential to reduce medication 1 ‘Knowing that it could potentially reduce my massive amount of 
medication I have taken over many years.’ 
 
 Nothing identified 4 
 
‘No’ 
What may have improved 
the programme 
   
 Self-management of storing recording 
in more accessible place 
1 ‘Probably more for me, but it would have been helpful for me to 





 Having programme and questions 
tailored more to migraines and not 
TTH 
1 ‘I think that the questionnaires and programme was probably 
more suited to tension headaches as I don’t believe stress is a 
significant factor in my migraines as I’ve had them since birth’. 
 
 Interaction with group participants 1 ‘It would be nice to check in with other participants too’ 
 
 Face-to-face check in 1 ‘Maybe a face to face check in part way through the course’ 
 
 Improved method to record 
headaches/medication 
2 ‘maybe an app to help collect data real time but appreciate this is 
a job to develop one’ 
 
 Nothing identified 2 
 
‘N/a’ 
Do you feel different to life 
with migraines/TTH than 
you did prior to the study? 
 
   
 Have more control 3 ‘I do feel different. I have never done anything like this before. I 
feel more in control after a decade. I control the early onset of 
the pain which in turn does not develop into an attack. I would 
not have thought it was possible’. 
 
 No change/little change 2 ‘not really.’ 
 
 More empowered 1 ‘I feel I can take more empowerment over the situation’ 
 
 Migraines no longer stop me from 
doing things 
1 ‘I am now not thinking about not doing things just incase a 
migraine attack happens’ 
 
 Now have extra coping tool/better 
coping tool to stop migraines 
3 ‘Yes, feel like I have an extra and very effective coping 
mechanism thank you sincerely.’ 
 
 More aware of triggers  
 
1 ‘This study has highlighted to me by keeping the headache diary 
that the source of my headaches is largely lack of sleep - which 
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was hugely helpful in terms of knowing how to help with my 
headaches.’ 
How do you feel about your 
future living with 
migraines/TTH? 
 
   
 More positive/optimistic 4 ‘I feel very positive and will continue with the self-hypnosis. I've 
been in plenty of situations since starting the study where it has 
really helped’ 
 
 Have extra tool to cope 2 ‘Feel like I now have a new tool to help with managing my 
headaches in the future - with using hypnosis’ 
 
 More aware of triggers 1 ‘I feel like I now have a new tool to help with managing my 
headaches in the future - with using hypnosis; and also of being 
more aware of my headache triggers’ 
 
 Feel able to wean off medication 1 ‘Will attempt to wean off prophylactic medication on completion 
of the study’ 
 





Answers provided to the open-ended questions were explored using content analysis 
via the generated categories seen in Table 8. Inter-rater reliability was 100% agreement, but 
was perhaps not a surprise, given that for several questions, there was only one category per 
participant due to minimal answer overlap.  
For the question ‘what did you least like about the programme and why,’ most 
respondents (six) could not identify any aspects, while five disliked the questionnaire and 
headache diary completion. One respondent disliked lack of symptom-change. Asked ‘what 
liked most about the programme,’ three reported feeling relaxed/soothed, two the 
administrator, two gaining a new tool to use, two giving time to their selves. Asked what 
barriers participants found to using the programme, the majority (eight) could not identify 
any aspect, two reported making time/prioritising the programme, while another two found 
work as a barrier. Asked if there was anything that helped participants use the programme, 
the largest single response (four) was ‘nothing identified.’ Two responded ‘self-
determination,’ and another two reported having the self-hypnosis recording stored on their 
phone as helpful. Asked ‘what may have improved the programme,’ two reported an 
improved method to record headaches, another two reported ‘nothing identified.’ Other 
answers included group participant interaction, additional face-to-face check-ins, and having 
the programme/questionnaires better tailored to migraines rather than TTHs. Asked if people 
now felt different to life with migraines/TTH than before the intervention, three responded 
they felt more in control, another three reported they had another coping tool to manage 
migraines/TTH.  One respondent provided a powerful response: “I do feel different. I have 
never done anything like this before. I feel more in control after a decade. I control the early 
onset of the pain which in turn does not develop into an attack. I would not have thought it 
was possible”. Two respondents reported no change to symptoms. The final question asked 
‘how do you feel about your future living with migraines/TTH.  The largest single response 
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(four) was ‘more positive/optimistic’. Three reported they were ‘not hopeful/optimistic’ or 
‘worried’. One respondent said they were more aware of their triggers, while another said 
they intended to wean off prophylactic medication. 
Broad positives included: increased control/empowerment, having a coping-tool, 
increased trigger awareness and stopping development into attacks, giving time to self, ability 
to relax and feeling positive/optimistic about the future. Broad negatives and suggested 
improvements included: no symptom changes, improved means of headache recording, 
feeling the programme was better TTH-suited, and that some were less optimistic. 
4. Discussion 
4.1 Overview  
The present study developed and conducted a pilot RCT of an intervention consisting 
of single session online group hypnosis plus 14-days of self-hypnosis. It was designed to 
reduce migraine/TTH symptoms via enhancement of self-efficacy, ILOC and expectancy. To 
the author’s knowledge, this is the first intervention which has combined online group 
hypnosis with a pre-specified period of self-hypnosis for migraines/TTHs. Alongside Flynn’s 
(2019) RCT comparing self-hypnosis with waitlist-controls, it is one of the few RCTs of 
hypnosis for migraine/TTH research since the mid-1990’s.  
As a pilot RCT, the study was designed to estimate effect sizes for a full-scale trial 
and was not fully powered to test the hypotheses. Nevertheless, in line with study hypotheses, 
results showed participants who received the hypnosis intervention reported significantly 
reduced mean daily headache scores at follow-up compared to waitlist-controls. Similarly, a 
statistically significant increase in the total number of medication-free-days was observed for 
the hypnosis group compared with waitlist-controls at follow-up. Interestingly, although there 
was a trend for the same effect on both measures at post-intervention, neither achieved 
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significance at this time-point. Thus, there was a suggestion these effects increased as time 
elapsed after the intervention. Similar findings were seen within Kirsch et al.’s (1995) meta-
analysis of hypnosis plus CBT for obesity. Here it was exhibited that treatment effects were 
moderated by length of follow-up, with increased effects demonstrated over duration post-
intervention (r =.59, p < .02). One implication of this is that in a full scale RCT it may be 
worth delaying the post-intervention time-point or designating the follow-up time-point as the 
primary time-point, rather than post-intervention.  
 Contrary to the secondary hypotheses, there were no significant improvements in 
total DASS score, depression, wellbeing, headache management self-efficacy, or ILOC. 
Similarly, expectancy, attitudes to hypnosis and suggestibility did not moderate outcomes, 
while changes in expectancy did not mediate the effects of the hypnosis intervention. 
Nevertheless, it is possible some of these were Type II errors, given this was a pilot study. 
Additionally, the attitudes to hypnosis scale demonstrated poor internal consistency and it is 
possible this contributed to the absence of moderation. Future research may look to re-
evaluate the use of this measure (or develop a more reliable instrument), given its last 
validation in 1987. Despite non-significant findings, it is worth noting that trends toward 
decreased headache frequency (p = 0.56) and anxiety (p = 0.88) were observed for the 
hypnosis group compared with waitlist-controls at four-week follow-up.  
Collectively, these findings suggest a brief online group plus 14-days of self-hypnosis 
intervention may be effective for migraine/TTH symptom and medication-use reduction, with 
significant differences potentially becoming more evident over longer time-periods post-
intervention. They also suggest sufficient basis to warrant further evaluation in a fully 
powered RCT and the obtained effect size estimates could be used in the power calculation.  
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The study findings support those of previous studies suggesting hypnosis can be used 
to reduce migraine/TTH symptoms (e.g., Flynn, 2019; Nolan, 1995). Similar to Nolan et al.’s 
(1993) findings they support hypnosis being delivered effectively in a group format and 
replicates the findings of Hasan et al. (2019) that hypnosis can be successfully delivered 
online. Additionally, like Flynn (2019), findings suggest participants partaking in self-
hypnosis may derive significantly improved outcomes than waitlist-controls. Moreover, while 
Richardson and Richardson (2012) have suggested web-based interventions are prone to high 
attrition, the rates in this study were low.  
Although changes in self-efficacy and ILOC measures were not observed, it is 
possible these measures were less sensitive to change over the study measurement period. It 
is possible that if a later follow-up period was measured (e.g., 6-months) that changes may 
become more apparent over time once individuals experiences further migraine/TTH 
symptom decrease. This contention is supported by the qualitative feedback answers where a 
large proportion of responses reflected themes of increased empowerment, control, and 
acquisition of tools to utilise for migraine/TTH symptom reductions.  
There was also a failure to find a mediating effect of post-intervention expectancy 
changes. While due to the small sample size, it is possible this was due to a Type II error, it is 
also possible that the timing of post-intervention expectancy assessment was too long (14-
days) from the baseline expectancy measure to accurately capture change. Similarly, the 
specificity of expectancy question asked, could have been better worded to incorporate time 
and context specific parameters within which the participant might conceptualise likely 
migraine/TTH symptom improvement to occur. 
93 
 
Overall, the study findings support running a fully powered trial. Assuming this trial 
confirms the beneficial effects of this intervention that are suggested here, then the below 
implications are likely to apply. 
4.2 Clinical and research implications 
Blanchard and Schwarz’s (1988) marker of clinical significance (headache symptoms 
reduced > 50% and no increase in medication use) was approximated for nearly half of the 
participants who experienced the intervention (7/15). Importantly, it also demonstrated 
significant effects from a small sample size that were obtained from the low resource-
dependent nature of a single session of group hypnosis plus self-hypnosis. Clinically, the 
significant findings for a small sample size are encouraging. Importantly, the potential to 
deliver an intervention that is effective, in an online group-format offers several advantages. 
These include time and cost savings, but also, the possibility of offering an intervention that 
would not need to be delivered over the multiple sessions required for the only other NICE 
guidance recommended non-medication-based intervention of acupuncture (NICE, 2015). 
This is something that is instead maintained by the individual via self-hypnosis in a self-
empowering manner. 
Additionally, participation would not be constrained by geographical limitations and 
proximity to services. Given expanding health service waitlists, and in the current context of 
Covid-19, the further exploration of the significant quantitative and qualitative beneficial 
findings of this intervention would seem valuable to potentially maximise treatment reach. 
Additionally, although the measures did not reflect significant changes in self-efficacy 
or ILOC, significant reductions in medication use were observed. Whether the self-hypnosis 
or suggestions for increased control (as reflected in some of the qualitative feedback) may be 
more meaningfully reflected in this ‘real-world’ change of significant medication-use 
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reduction remains uncertain. It does however reflect the possibility of a potential intervention 
that for some may reduce medication/s used (as reflected in the multiple medication-types 
used by study participants). Considering the brief nature of the present intervention, and the 
minimal adverse effects shown, it would seem practical to offer hypnosis as an early 
intervention (before alternatively embarking on long term medication use). 
Of interest, within the study there was a long chronicity of time-period since diagnosis 
(average 15.8 years within this study) and high proportion of participants with chronic 
migraine (20%). This raises the question whether there is a differential response for those 
who feel more strongly governed by their chronicity and perceived entrenchment of 
symptoms compared with more recently diagnosed individuals. Further research which 
explores whether migraine/TTH experiencers respond differently to hypnosis on this basis 
will be of benefit (e.g. by stratifying a fully powered trial sample by migraine/TTH chronicity 
and examining if these moderate outcomes). Additionally, as discussed, research that 
explores longer periods of follow-up will be of benefit. Given that trends for improvement 
increased from post-intervention to follow-up and group differences tended to increase over 
time, this will be important to examine. 
4.3 Limitations  
Within the present study, the variation in medication type used prevented medication 
type and dosage comparisons between time-points. While this speaks to wider issues of poly-
pharmacy prescription within migraine/TTH populations (Muhit & Rahman, 2010), in future 
studies it would be beneficial to request participants remain on the same medications 




As this was a pilot study, the sample size was small. Given the downward trends 
observed over time in migraine/TTH symptoms, it is possible that other significant results 
may have been observed, had a larger sample been utilised (e.g., migraine/TTH frequency, 
total DASS and anxiety scores). Additionally, it should be noted that the present study used a 
passive control group. As future studies are designed with larger samples, the use of an active 
comparison group to ensure hypnosis specific, as opposed to generic factors are responsible 
for improved outcomes will be important to explore.  
Furthermore, the disproportionate number of females of white ethnicity within the 
sample make it difficult to generalise findings to populations that are ethnically diverse and 
male. This is important given that there is some evidence for differential pain responses 
according to ethnicity (Fabian et al., 2011). Therefore, future studies would benefit from 
seeking to recruit from non-white and male populations to ensure a more representative 
sample of the general population.  
Further study limitations lay in the time constraints imposed by the nature of the 
single group session delivery. Subsequently, it was not possible to capture suggestibility via 
standardised measures, and a bespoke measure was created to capture this. It is therefore 
possible suggestibility was not adequately measured, and this might explain why it was not 
observed to be associated with outcomes. Additionally, in developing the intervention content 
and hypnosis protocol, particular challenges lay in ensuring a maximal number of people 
benefited from the same group intervention. This was of relevance for bringing participants’ 
individual triggers to the fore, utilising imagery and metaphors neutral enough to be accepted 
by as any people as possible. These generalisations may have limited individual responses to 
the present intervention. This will be helpful to explore regarding further individualisation of 
protocol whilst maintaining generalisability of effects.  
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Additionally, as described above, expectancy was shown not to mediate outcomes. It 
should be noted that the development of Section A research questions regarding response 
expectancies were developed after the present intervention began. Therefore, the timing of 
measure and question asked to capture response expectancy may hopefully be better designed 
so that future studies improve specificity of post intervention expectancy measurement closer 
to the timing of intervention, while also ensuring the response expectancy question is as time 
and place specific as possible. This is important given the possible mediatory role played by 
response expectancies for hypnosis interventions. 
5. Conclusion 
 Significant difference in mean daily headache rating and number of medication-free 
days were observed for the hypnosis group compared with waitlist-controls at follow-up. 
However, the small sample size and disproportionately white, female sample limits 
generalisability. Nevertheless, finding significant differences with a small sample size 
suggests further large-scale research is warranted. If further supported, hypnosis may not only 
provide increased benefits of widening treatment access through a brief intervention, but 
individuals may also develop less medication-needs. It is possible also that self-
empowerment via continued use of self-hypnosis and self-generative improvements from 
further reductions in migraines/TTHs may be observed. The potential for the intervention to 
be delivered in a brief, cost, and resource-efficient manner, that is not only relatively safe, but 
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Appendix B: Study recruitment advert and information-sheet 
 
Hypnosis and migraine/tension-type headache study 
  
• Do you experience migraine or tension-type headaches? 
 
• Would you be interested in a free online and self-hypnosis course for migraine and 
tension-type headaches? 
 
• Are you interested in taking part in research to explore if hypnosis is helpful for 
migraine/headache symptom relief and an improved quality of life? 
  
Can I take part? 
• You are a U.K. resident aged between 18-80. 
 
• You have a diagnosis of migraine or tension-type headache from your G.P. or 
neurologist. 
 
• You have had at least one headache every 2 weeks over the last 3 months. 
 
• You have a laptop/tablet and internet access. 
  
What is involved? 
• One evening online group session, followed by listening to a guided self-hypnosis 
mp3 at home for 20 minutes daily for a 2-week period. 
• The completion of a daily headache diary and some questionnaires. 
  
For more information on suitability of study please use the link below and contact: 
  
Paul Davies, Trainee Clinical Psychologist at: 
  





This research has been approved by the Salomons Institute for Applied Psychology Ethics 















An Evaluation of Brief Online Hypnosis for Migraine and Tension-type Headaches 
  
INVITATION 
We would like to invite you to consider taking part in a research study on the effect of group 
and self-hypnosis in the relief of migraine and tension-type headache symptoms. This is 
being run by Paul Davies, a clinical psychology doctorate student at the Salomons, 
Canterbury Christ Church University clinical psychology programme. This study is supervised 
by Dr Fergal Jones, also from this university, and Dr Rob Agnew. This project has been 
approved by the Salomons Research Ethics Committee. 
  
WHO CAN TAKE PART? 
This study is open to adults aged 18-80, who are resident in the U.K. and who have received 
a diagnosis of migraine or tension-type headache from a GP or specialist doctor. If you have 
a letter confirming this diagnosis and are happy to provide a copy to the research team, 
then please do so (but this will not be essential). You will also need to have experienced 
migraines/tension-type headaches once every two weeks for the last three-month 
period.  Other than migraines or tension-type headaches, you’ll need to be physically and 
mentally well and not have diagnoses of epilepsy, psychosis, personality disorder, 
medication-overuse headache and/or receiving psychiatric medication. You’ll also need to 
be able to understand written and spoken English and have internet access via a 
laptop/tablet. 
  
WHAT WILL HAPPEN 
In this study, you will be invited to take part in an online group hypnosis session which 
includes the provision of background information about migraine and tension-type 
headache early warning signs, and what hypnosis is, followed by a 30-minute group 
hypnosis session. You will then be provided with a recording of guided self-hypnosis 
alongside guidance and instructions on how to follow this at home on your own. You will be 
asked to listen to this recording daily over the next fourteen days at home. Ongoing contact 
with the researcher via email will be provided for follow up questions should any further 
support be required during this process. 
  
If you consent to take part in the study, there may be a waiting period until a sufficient 
number of people are recruited to the study before we can start the research. Once this 
number of people has been reached, you will be contacted and asked to complete the initial 
questionnaires and headache diary to be recorded for two weeks.   
  
Once completed you will then be allocated to either an immediate or delayed intervention 
group. The reason that there are 2 groups is so we can measure whether it is the effect of 
hypnosis that improved migraine/tension-type headache symptoms alone rather than just 
improving over time. After allocation to immediate or delayed intervention group you will 
receive notification of this. Please note there may then be an approximate 1 to 5 week wait 




Please be aware that if sufficient numbers of people are not recruited, then it is possible the 
study may not go ahead; however we do not expect this to be the case. You will be 
contacted regularly to update you regarding progress in relation to recruitment of sufficient 
numbers for the study to begin. 
  
You will also be asked to complete several questionnaires and complete a daily 
migraine/headache diary for 14 days prior to the group hypnosis session. These will be 
repeated 2 weeks later (after the hypnosis is finished) and again 4 weeks after that, to see 
how long any benefits of the hypnosis last. 
  
HOW MUCH TIME WILL IT INVOLVE? 
The study typically takes 2-5 minutes per day to complete the migraine/headache diary 
during the pre-trial period. Then 2 hours in the group session, followed by 20 minutes self- 
hypnosis per day for 2 weeks and the recording of daily symptoms (approximately 5 minutes 
per day) upon completion of the trial and again 4 weeks later. In addition, on three 
occasions you’ll be asked to complete a batch of questionnaires. We estimate these will 
take about 25 minutes to complete on each occasion. 
  
DO I HAVE TO TAKE PART? 
Your participation in this study is voluntary and you have the right to withdraw at any stage. 
You may decide to stop being a part of the study at any time without explanation. You have 
the right to ask that any data you have supplied to that point be withdrawn/destroyed. You 
will be able to omit or decline to answer or respond to any question that is asked of you. 
  
You will be able to have your questions about the procedures answered (unless answering 
these questions would interfere with the study’s outcome). If you have any questions as a 
result of reading this information sheet, you can ask the researcher before the study begins. 
  
BENEFITS AND RISKS 
It is possible that the hypnosis may reduce your migraine/tension-type headaches. 
However, as this research is breaking new ground, we cannot guarantee that. 
  
We believe the study to be low risk and hypnosis is considered a generally safe procedure. 
However, as with any relaxation-based technique, it is possible that some individuals may 
experience unpleasant responses/emotions. You’ll be able to talk about these with the 
researcher and withdraw from the study at any time. 
  
Should your migraine/tension-type headache symptoms worsen significantly during the 




We will store the data you provide us with securely and confidentially. 
  
Limits of confidentiality: In the unlikely event that during the study we become concerned 
for your safety or the safety of someone else, we may need to break confidentiality to liaise 
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with the appropriate services to ensure your and/or their well-being. We would try to talk to 
you about this first. 
  
When your role with this project is complete, your data will be anonymised. From that time, 
there will be no record that links the data collected from you with any personal data from 
which you could be identified (e.g., your name, address, email, etc.). Up until the point at 
which your data have been anonymised, you can decide to withdraw your data from 
inclusion in the study. Once anonymised, this data may be made available to researchers via 
accessible data stores and possibly used for novel purposes. The data will be retained for 10 
years after the study is complete.   
  
FOR FURTHER INFORMATION 
Paul Davies will be glad to answer your questions about this study at any time. You may 
contact him at p.davies253@canterbury.ac.uk or 07784192447. 
Participants who wish to be updated on study findings will be provided summaries via their 
email addresses. 
  
IF YOU HAVE A CONCERN OR COMPLAINT 
If you have concerns or complaints that you do not feel can be addressed by the researcher, 





























Appendix C: The Headache Screening Questionnaire (HS-Q) 
 
 














































Appendix D: Measures 
 
 











Depression Anxiety Stress Scale-21 



























The Warwick–Edinburgh Mental Well-being Scale (WEMWBS) 


















































The Headache Specific Locus of Control Scale 
 






















































The Headache Management Self-efficacy Scale (HMSE) 
 
























































Credibility/expectancy of change questionnaire 
 



















































Attitudes towards hypnosis scale 
 





















































Experience of hypnosis suggestibility questionnaire 
 
From the preceding exercise, how much from 0-10 (0= no response, 10= maximum response) did you 
experience each of the following: 
 
1. That you felt unable to open your eyelids when asked to do so. 
 
 
          1      2      3      4      5      6      7      8      9       10 
 
 
2. That you felt unable to unclasp your hands when asked to do so. 
 
 
          1      2      3      4      5      6      7      8      9       10 
 
 
3. That you felt your arm becoming heavier when asked to do so. 
 
 
          1      2      3      4      5      6      7      8      9       10 
 
 
4. That you felt your legs becoming colder and/or warmer when asked to do so. 
 
 

























Appendix E: Ethics approval document 





































































Appendix G: Hypnosis Taster session Script 
Hypnosis taster and practical session 
Take a moment to make yourself comfortable and prepare to begin to relax. Rest your feet flat on 
the floor and place your hands on your lap. Close your eyes and focus on the sound of my voice. The 
key to deep relaxation is to apply gentle attention. You will find that you can relax surprisingly 
deeply simply by focusing on the idea of letting go. Don’t try too hard- be relaxed about relaxing. 
Allow yourself to enjoy feelings of relaxation in an easy and gentle way. If your mind wanders, that’s 
normal- it really doesn’t matter- just acknowledge this before gently returning to the sound of my 
voice. Don’t try to force yourself to concentrate or block out distracting sounds or noises from your 
mind. Simply take a position of non-worry- any sounds or noises you hear will help you to deepen 
your journey into hypnosis. Your role is to remain as comfortable and as open as possible- You will 
be aware of my words and you will only accept suggestions which you choose to accept. So, as you 
rest there with your eyes closed, know that in a few moments you can ease into a wonderful state of 
deep hypnotic relaxation, where you find positive thoughts and feelings flow easily and naturally, 
where your imagination becomes stronger and more vivid- focused on the ideas and suggestions you 
will hear of deep relaxation that you then take into your daily life. 
INDUCTION 
Now just follow my words and you’ll discover that you respond fantastically well to hypnosis. In a 
few moments, I will ask you to open your eyes and look up at your ceiling overhead. Fixing your eyes 
on one point will make them strain and feel very tired. You can help by imagining your eyelids feel 
increasingly heavy and telling yourself they want to close. When your eyelids close, let yourself relax 
and continue relaxing. Now turn your gaze up behind your shut eyelids, and very slowly open your 
eyes again. Open your eyes slowly and imagine that you’re staring into a fixed point in the ceiling 
overhead. Stare deeper and deeper and imagine you can feel it sinking deep into your eyes. Now in a 
moment I’m going to begin counting from 5 all the way down to zero. As I count, count down with 
me in your mind. Imagine with each number we count that your eyelids feel heavier, more tired, 
more sleepy- like they are made out of heavy, thick lead. Let them close when they want to- don’t 
resist- let them close as soon as they want to. Beginning now-5, 4, 3, 2, 1 zero. Let them close all the 
way down. Let them relax so completely that it feels as if the muscles of the eye have forgotten to 
work. It feels as if they are sealing comfortably shut, as heavy as lead. Indeed raise your gaze behind 
your tightly shut eyes. The more you imagine opening them, the tighter sealed they become. 
SLEEP NOW. 
Relax them completely, let go. Relax your eyes, relax your face, relax your body, relax your mind. 
SLEEP NOW. 
Now take a deep breath and send a wave of pleasant relaxation through your body and through your 
mind. As you do so, let go and relax completely, and utterly, surrender to the process and let go. 
Take a breath and let yourself relax as deep as you can right now- feel the feelings in your body- and 
allow yourself to move gently on and become relaxed and indifferent towards external things for a 
while and focus on accepting the here and now…. for your experience of time may seem to pass 
quickly in hypnosis or indeed to seem sped up and slowed down at the same time…. just forget 
about everything else for a while and listen to my words… Keep your eyes closed and go deeper into 
137 
 
hypnosis….. send a wave of relaxation from the top of your head right down through your body all 
the way down into your fingers and into the soles of your feet….. sleep now sleep now sleep now  
……. 
Eyes closed shut exercise  
Now imagine your eyelids are so heavy that they are sealed shut permanently - locked heavily shut- 
your eyelids feel so heavily shut, the more you try to think about them being lifted, the more they're 
sealing shut now. As you exhale, make an effort and try to gently push against that heaviness and try 
to get those eyelids wide open- in fact- isn’t it interesting- you notice that the more you try, the 
more they are closing- closing closing- relaxing and sealing heavily shut-now as you inhale, let go 
completely and find the eyelids growing twice as heavy, sealing shut- locking shut -twice as tightly- 
as you exhale, try again, and make a bigger effort you find the eyelids are closing closing further 
down, down – relaxing, and sealing heavily shut- the more you try to get them open, the more they 
are closing heavily shut -and relax completely- good now stop trying- let go and relax completely- 
and go deeper into hypnosis -you may have noticed when you imagine your eyelids are sealed shut 
they actually feel too heavy to open- now forget about the eyes locking shut and just go deeper into 
hypnosis.  
Hand clasping exercise (participant is asked to imagine experience of hands clasping together 
tightly). 
Now shift your attention to your hands- put your hands together- interlock your fingers and raise 
your arms straight in front of you and clasp your hands together -interlock the fingers tightly- press 
the palms of the hands together as if they are stuck fast with glue- the more you squeeze and 
tighten those fingers the more the hands become stuck together -imagine the hands are merging 
into one solid block of iron -the fingers intertwine together - the hands are so tightly clasped stuck 
together that it feels like too much effort to make them separate now- as you continue to imagine 
your hands stuck together let the belief that they're stuck fast dominate your mind -as you exhale -
slowly make an effort and try to get those hands apart and find them sticking tighter together- the 
more you try to make them separate the more they are stuck fast together with your fingers locked 
together- as you breathe in, the hands lock tighter still -as you breathe out try again and find the 
more you try to make an effort the more the hands are locking tighter and tighter together they 
remain stuck together until I say the word relax in a few moments time………. relax now…….. quit 
trying……… let go completely and go deep into hypnosis……. your hands now relax and you're free to 
pull them apart easily relax your hands and place them on your lap……… perhaps you noticed how 
imagining your hands sticking together made them actually feel stuck together…….. isn’t that 
interesting??r now forget about their hands locking together for a while and just go deeper into 
nicest  
 
Arm heaviness exercise (participant is asked to imagine experience of arms beginning to feel heavy). 
Now, focus on your arms please……. raise your right arm and straighten it out in front of you and 
raise it above your head and leave it suspended there for a moment….. with your palm facing 
down…… in a moment your arm will begin growing heavier and heavier…… so much so that it feels 
like sinking down all by itself to rest by your side or on your lap……. Indeed, your arm seems to grow 
2 times heavier………you're responding well….. just let it grow heavy and it will want to sink down at 
its own rate…….. if you imagine your arm feeling heavy your arm will begin feeling heavy….. 
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imagining a feeling or movement tends to make it happen in our body…. Isn’t that interesting?? keep 
your attention resting on the arm from deep in the shoulder all the way down to your finger 
tips………. now imagine your arm is growing even heavier and heavier…… your arms feel heavier and 
heavier….. the arm is growing heavier and heavier……….. its now sinking down down down…. the 
arm feels weary, tired and heavy more tired and heavy with each moment passes the hand and wrist 
are loose relaxed and heavy……. pulling the arm continuously down as if they have the weight of a 
cannonball on the end of the arm….note that as every tiny sensation, every feeling in the arm as it 
grows heavier and heavier….. the more you think about that arm…. the heavier it's becoming….. the 
more it wants to sink gently down, down, down as almost as if you can picture a heavy blanket of 
lead over the arm….. a heavy weight pushing it down pressing it down drawing it down more and 
more – im now going to count form 10……. 10 heavier and heavier 9.. down down…. 8 heavier and 
heavier and heavier 7,6 sinking down down, down 543 sinking all the way down to one all the way 
down ……zero…. its all the way down… right down let go completely and go deeper and hypnosis 
good now forget about all those feelings of happiness and just gently rest both your hands in a 
comfortable position you're learning how to use the power of your mind by letting yourself imagine 
feelings that inevitably move the muscles of the limbs this is the basis of hypnotic suggestion you're 
now learning to understand suggestion an learning how to respond more powerfully to suggestion 
when you choose to let it happen  
Leg cooling/warmth exercise (participant is asked to imagine experience of legs beginning to change 
in temperatures from warm to cool). 
Now I want you to bring your attention to your right leg and what I want you to imagine is you can 
start to feel a little sensation throughout your right leg of temperature and the temperature is 
beginning to cool and it cools down as colder and colder you can start to feel your right leg feel very 
different to your left leg becoming colder and colder and then what you notice is suddenly a very 
chilly indeed and you can notice how to cooling sensation is running from the top of your leg all the 
way to the bottom and you go deeper and hypnosis and as you do notice your leg is feeling colder 
and colder and colder again two times colder three times cold so cold it all the sudden it seems to 
feel too cold and as you do and you notice you realise you have control and when I say it begins to 
feel warmer you notice your leg the temperatures rolling all the way down as if it was sitting by a 
warm campfire and you can feel the heat coming off their campfire onto your leg and your legs 
slowly raising temperature 1 degree two degree more become so warm you feel a pleasant tingling 
sensation going all over that Ryan leg isn't it interesting how you can feel that warmth rising from 
the bottom and as he do I want you to slowly bring your attention away from your leg and realises 
returning back to not wanted the normal temperature before and you bring your attention to 
yourself and your body and you realise what a wonderful candidate you are hypnosis because 




And slowly we will soon return fully back to the room around us. You notice the sounds around you. 
Feel the sensations of the seat and floor against your body. More and more you are feeling awake 
and alert, and I ask that you now gently bring yourself fully in to the room around you. Slowly 




Appendix H: Main group hypnosis script 
Now, take a moment to make yourself comfortable and prepare to begin to relax. Rest your feet flat 
on the floor and place your hands on your lap. Close your eyes and focus on the sound of my voice.  
Now turn your gaze upwards behind your shut eyelids, and very slowly open your eyes again. Open 
your eyes slowly and focus on a fixed point in the ceiling above. Stare deeper and deeper and 
imagine you can feel the hypnosis sinking deep into your eyes. Now in a moment I’m going to begin 
counting from 5 all the way down to zero. Let your eyes close when they want to- don’t resist- let 
them close as soon as they become too heavy to stay open. 5, 4, 3, 2, 1 zero. Let them close all the 
way down. Let them relax so completely that it feels as if the muscles of the eyes have forgotten to 
work. It feels as if they are sealing comfortably shut, as heavy as lead. Indeed, raise your gaze behind 
your tightly shut eyes. The more you imagine opening them, the tighter sealed they feel and 
become. 
SLEEP NOW. 
Relax them completely, let go. Relax your eyes, relax your face, relax your body, relax your mind. 
SLEEP NOW. And, just utterly and completely, give yourself permission to surrender to the process 
and let go. 
DEEPENER 
Now, focus your attention all the way down upon the soles of your feet. You’re now going to relax a 
few levels deeper, relaxing through each part of your body. Imagine you’re beside a beautiful blue 
clear lake and it’s the middle of summer, with a cool breeze cooling your body temperature 
perfectly. With your attention focused on your feet, you take a small step into the water, now 
imagine that a calming blue sensation is spreading over the soles, up and around your toes, just as 
the summer water waves lap gently over your feet. Imagine the peaceful and gentle waves and 
picture it beginning to spread calm and soothing energy upward throughout your body (pause 5-10 
secs). 
Now imagine that feeling rising from your feet, dissolving every last ounce of tension from the 
muscles as it does so. Now flowing all the way over the ankles and up through the legs, send that 
feeling up through the calves and the shins, up into the knees. Let the knees relax completely. Now 
imagine that feeling rising up through the thighs towards the hips. Imagine both legs relaxing 
completely (as if they were made of thousands of loose rubber bands). Let go of every last ounce of 
tension in the left leg and the right leg, in both legs at once. Deep breath in and let go…..(pause) 
Now imagine that feeling spreading up into your stomach, into the waist, up through the top half of 
your body. Now imagine that feeling spreading up into the chest and shoulders, filling the whole 
trunk of the body. Imagine relaxation spreading deep inside the body, right into the internal organs, 
soothing and healing as it revitalises your body and mind. (pause) 
Now send that feeling up into the neck and the shoulders, feel the calm cooling blue spreading over 
the shoulders and down into the arms. Let the arms turn loose, completely limp and heavy, right 
down into the very tips of the fingers. Rest your mind on the top half of the body and feel the 
natural movements of your breathing- gentle deep breath in, and let go (pause) 
Continue to relax the body so deeply that you can feel your breathing changing all on its own, 
becoming more slow and gentle. Let your breathing find its own rhythm and pattern. Now imagine 
that sense of relaxation spreading from the base of the spine all the way up through your back, right 
up to the base of your neck. Let the sensation flow over the back of the head, over the scalp and 
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down over the forehead, feeling it as a cooling sensation as it does. Relax all the muscles in the eyes 
and around the eyes. 
Let the feeling spread down into the cheeks and down into the jaw. Send the relaxation feelings into 
the mouth, soften all the muscles in the mouth, let the tongue rest broad, flat, heavy and silent. Let 
the tongue relax completely. Relax all the muscles of the face completely, let them drop, soften and 
ease into a completely relaxed expression. Notice how that feels, how the facial expression now 
feels more peaceful. You now let go, release and are as deeply relaxed as you could ever possibly 
imagine. Surrender- let go  
SUGGESTIONS 
You are now growing so deeply relaxed- that the words I say take root permanently, like the seeding 
of an acorn it begins to grow there powerfully and effectively into the roots and trunk of a tree of 
great internal strength. These suggestions that I will suggest to you will begin to support you shaping 
a greater influence over the way you want to think, over the way you want to feel, and how you 
want to act in your life generally, and for when migraines and headaches emerge. These powerful 
changes will remain deep in the core of your being long after we finish our session tonight. They will 
continue to multiply in their impact as you complete your daily self-hypnosis-and will grow this 
powerful influence just as strongly, just as surely- when you are back at work, or back around others, 
and back at home. You’re now feeling so very deeply relaxed, that every single suggestion is being 
absorbed so very deeply- and these words will help change your life, exactly as you want it to be. 
Breathe deeply in and release, let go, relax. Repeat. 
You are becoming aware of your ability to create change and manage in day-to-day situations 
exactly as you would like to. You are becoming more confident in your ability to relax and take 
control of how you feel in your mind, your body and your life. More confident in your ability to cope 
with stressful situations. You feel more able to share how you feel with others, more able to choose 
to eat healthily, exercise and be kind to yourself. You notice more that you have control over how 
well you can sleep, relax, de-stress and be kind to yourself. More and more you are able to pace your 
activity in a steady fashion, so that you are not over-exerting yourself when feeling well, or doing 
anything less than you may be able when you are feeling unwell. Even on a difficult day, you are still 
able to do something, no matter how small it is- even if it is to remind yourself you are doing all you 
can. With each extra little thing you do, you are further re-taking control and ownership of the life 
you want to create for yourself. Take a deep breath in, release, relax, let go. 
More and more you are developing a deeper awareness of your early signs and triggers of physical 
discomfort and stress related to migraines and headaches. The more you are aware of this, the more 
you notice you are able to take control over these situations as they emerge: to notice them and 
take increased charge and diminish their influence in your life. Every time you have this thought 
brought to your conscious awareness, it is just like you shrink the size and power of the migraine and 
headache in half so they begin to recede.  The power of your belief and thought reduces them in half 
again every time you bring these thoughts to your awareness. With each step taken in this direction 
the more you are becoming calm, relaxed, and most importantly, empowered. By doing more, you 
are becoming more in control of the first signs of physical tension. You are noticing your patterns of 
thought- adopting more and more a balanced position and way of thinking. Your self-talk is kinder 
and more and more you value who you are as a special and unique individual. As you do, you 
become more relaxed and at ease. Indeed, you can visualise and imagine how you respond when the 
first signs of physical tension emerge and realise with each step you take towards the vision of life 
you wish to adopt.  
So, I ask now that you can bring to mind that image of your typical triggers or emergent situation 
when migraine or headache is around. Now I want you to imagine that you are there now. You take 
a deep breath and slowly exhale. As you do, you silently say to yourself: ‘I have this’- ‘I take back 
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more control’, no matter how strongly migraine or headache is around, I have power and I have 
strength. Right now, gently clench your right fist tight. This is your cue, your reminder that you have 
this inner strength to remind migraine and headache you are here and you have ownership of you. 
Every time you bring this thought to mind, it shrinks the size and presence of migraine in half, and 
half again. Gently clench and unclench your fist. Each time you do this, it has the effect of shrinking 
the power of migraine and headache. Repeat this again. Migraine begins to retreat and starts to 
shrink in your presence once more- indeed, every time you do this in the real world, you can 
instantly recapture this feeling of strength and control- each time the migraine and headache begins 
the process of slow retreat and shrinking in its attempts to control your way of living and life. Now 
gently relax and release that fist, take a deep breath in and release, let go, repeat.  
Now with whatever residual presence of migraine and headache is left, I want you to notice where 
you feel its presence- whether it be in your head or your body- and the general tension, pressing or 
pulsation you normally feel. Wherever you notice this, I want you to now imagine that you can 
transport yourself there instantly as a miniature traveller inside your body- each time you clench 
your right fist you imagine shrinking down into a tiny yet powerful version of yourself- so tiny that 
you can imagine travelling instantly through the blood vessels of your body to the point of tension- 
you can imagine with the onset of the migraine and headache- go there now- shrink down to 
miniature size and travel to the place of your discomfort. Once arrived you use your inner strength 
to push and gently massage those pressured blood vessels apart- easing and releasing tension-you 
allow the flow of oxygenated blood to your body, to your limbs, to your face- you allow the flow of 
healing thought and calming energy to where your body needs it- you allow the flow of healing 
where your body needs it. Breathe in, slowly exhale and say to yourself: I take back more control. 
Indeed,as you say this- You remember that pain is an experience processed within the brain and not 
the body. Made of many layers, this is something you now have increased control over. You realise 
you have control over this with the power of your beliefs for change. 
 As you take increased ownership over migraines and headaches, you know you can release a further 
soothing blue cool wave of energy to be released through your body and area of pain as you wish. 
Now imagine that whenever you experience the onset of your migraine or headache (or indeed its 
continued presence), you have the ability to travel inwardly through your body, and release areas of 
tension to lower the feeling of discomfort instantly and release the blue, soothing waves of pain 
relief to wherever you direct it in your body. You can instantly visualise this and direct this to lower 
the sensation in your body. Imagine now directing this release whenever you need it. Feel how good 
it feels to have this instant control. Really experience that instant cool relief. Let your smile widen as 
you now know you are beginning to equip yourself with the necessary tools to take direct control 
over your level of pain experienced. Whenever you experience this discomfort in the real world, you 
can instantly retake control by clenching your right fist and visualising this process- of travelling to 
the point of discomfort in your body and using and relaxing the body as needed. Breathe out, 
release, relax, saying to yourself I take back control and power over my life and my pain. 
Now, I want you to bring to mind your preferred future. Visualise and imagine this. What does it look 
like- what are you doing more of- with others, by yourself?  How do you feel? What emotions are 
you feeling? Happiness? Laugher? Warmth? love? Now, imagine stepping into your life in the future- 
a future where you have increased control over your migraine, over your headaches.  How is life 
different- what do you notice that is different about you? What do you say to yourself differently- 
what do you do differently? How do you act different- how do you respond differently to migraine- 
to headaches? Feel it believe it- let this experience sink deep into your body and mind. Feel how 
amazing this feels- let your smile emerge and widen. Deep breath in- release and exhale- say to 
yourself I take back control. 
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You now know that you can enter situations with this control – any time you can clench your fist- 
take a deep breath- and visualise travelling to the seat of pain in your body and release it- and even 
when migraines are still present- you can speak to them and you- by reminding them that you have 
control. This becomes a more automatic process and with a calm relaxed self-assured confidence 
knowing you can and do handle these situations better and better every time-   
Now- listen to these words: every day I now feel more relaxed, strong, confident, more capable to 
take charge and control over pain and discomfort in my life. Repeat 3 times as they create a more 
powerful, beneficial and lasting transformation in your life. Picture yourself in the situation you want 
to deal with, as if it’s happening right now, and imagine yourself repeating the suggestion with me 
Every day in every way I feel more relaxed, in control, calm and confident that I can reduce the 
discomfort of my symptoms. I have control and take charge of them. 
Know that you are making this change- growing- becoming empowered- you are creating amazing 
life changes! You realise your beliefs dictate your present and future and our ability to imagine what 
is possible- to imagine and feel the life we want to live! Indeed, every day that you listen to the self-
hypnosis on your own- you create incremental, automatic and exponential change for the life you 
are creating exactly as you want it to be. Take this amazing feeling of growing inner strength and 
empowerment in relation to migraines, headaches and your wonderful, special life ahead of you! 
EMERGENCE 
And now I will count from 5 all the way down to zero. As I count down with each number you will 
slowly begin to feel more aware of your surroundings in a calm, refreshed and pleasant manner. 5 
aware of your physical sensation of your body contacting the seat and floor around you. 4 aware of 
the sounds of the outside world and room around you. 3 smelling the room, 2 slowly beginning to 
feel the light of the room around you and beginning to feel your eyelids flutter ready to open. 1 
open your eyes back into the room, calm and relaxed. Zero, peaceful, calm and ready to take these 












Appendix I: Comparison of baseline measures between participants allocated to the 














































Z -.759 -.116 -.716 -.033 -1.025 -.562 -.083 -.578 
Asymp. Sig. 
(2-tailed) 




.465b .909b .483b .987b .318b .590b .935b .568b 
a. Grouping Variable: Cohort 





















Appendix J: Post-intervention measures between group differences 
Mean daily headache 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   AV_DAY_MIG_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 8.408a 2 4.204 50.269 .000 
Intercept .020 1 .020 .241 .627 
AVDAYM_0 8.386 1 8.386 100.280 .000 
COHORT .109 1 .109 1.306 .262 
Error 2.425 29 .084   
Total 21.761 32    
Corrected Total 10.833 31    
a. R Squared = .776 (Adjusted R Squared = .761) 
Total Headache frequency 
 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   TOTAL_MIG_FREQ_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1086.964a 2 543.482 41.503 .000 
Intercept 4.196 1 4.196 .320 .576 
TOTAL_MIG_FREQ_0 1086.237 1 1086.237 82.950 .000 
COHORT 13.769 1 13.769 1.051 .314 
Error 379.755 29 13.095   
Total 4113.000 32    
Corrected Total 1466.719 31    




Total number of medication free days 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   NO_MEDS1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 518.409a 2 259.204 20.345 .000 
Intercept 53.822 1 53.822 4.225 .049 
NO_MEDS0 495.749 1 495.749 38.912 .000 
COHORT 35.590 1 35.590 2.793 .105 
Error 369.466 29 12.740   
Total 3166.000 32    
Corrected Total 887.875 31    








2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASS_DEP_TOTAL_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1503.389a 2 751.694 13.726 .000 
Intercept 60.010 1 60.010 1.096 .304 
DASS_DEP_TOT_0 1502.681 1 1502.681 27.440 .000 
COHORT 5.444 1 5.444 .099 .755 
Error 1588.111 29 54.762   
Total 6056.000 32    
Corrected Total 3091.500 31    
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 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASS_ANX_TOTAL_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 895.005a 2 447.503 16.705 .000 
Intercept 15.260 1 15.260 .570 .456 
DASS_ANX_TOT_0 894.471 1 894.471 33.390 .000 
COHORT 53.563 1 53.563 1.999 .168 
Error 776.870 29 26.789   
Total 3212.000 32    
Corrected Total 1671.875 31    
a. R Squared = .535 (Adjusted R Squared = .503) 
 
DASS Full Total 
 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASSFULL1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 6810.339a 2 3405.169 9.807 .001 
Intercept 509.301 1 509.301 1.467 .236 
DASSFULL0 6715.437 1 6715.437 19.340 .000 
COHORT 329.836 1 329.836 .950 .338 
Error 10069.661 29 347.230   
Total 46648.000 32    
Corrected Total 16880.000 31    
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 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   WEM_TOT_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 2245.807a 2 1122.903 16.462 .000 
Intercept 49.046 1 49.046 .719 .403 
WEM_TOT_0 2221.101 1 2221.101 32.561 .000 
COHORT 49.480 1 49.480 .725 .401 
Error 1978.162 29 68.212   
Total 70381.000 32    
Corrected Total 4223.969 31    




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   HMSE_TOTAL_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1687.707a 2 843.853 7.946 .002 
Intercept 243.111 1 243.111 2.289 .141 
HMSE_TOTAL_0 1687.140 1 1687.140 15.886 .000 
COHORT 2.087 1 2.087 .020 .889 
Error 3079.793 29 106.200   
Total 370280.000 32    
Corrected Total 4767.500 31    
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 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   ILC_TOTAL_1   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1725.205a 2 862.603 68.786 .000 
Intercept 163.026 1 163.026 13.000 .001 
ILC_0 1713.123 1 1713.123 136.609 .000 
COHORT .018 1 .018 .001 .970 
Error 363.670 29 12.540   
Total 46342.000 32    
Corrected Total 2088.875 31    













Appendix K: Follow up measures between group differences 
Average daily headache 
Between-Subjects Factors 




2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   Average daily headache   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 5.882a 2 2.941 32.595 .000 
Intercept .029 1 .029 .323 .575 
AVDAYM_0 5.471 1 5.471 60.630 .000 
COHORT .409 1 .409 4.530 .043 
Error 2.436 27 .090   
Total 14.584 30    
Corrected Total 8.318 29    
a. R Squared = .707 (Adjusted R Squared = .685) 
 
 
Mean daily headache Mann Whitney test 
 
Ranks 
 Cohort N Mean Rank Sum of Ranks 
ADM0MT2 Intervention_cohort 13 19.31 251.00 
Control_cohort 17 12.59 214.00 





Mann-Whitney U 61.000 
Wilcoxon W 214.000 
Z -2.074 
Asymp. Sig. (2-tailed) .038 
Exact Sig. [2*(1-tailed Sig.)] .039b 
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a. Grouping Variable: Cohort 
b. Not corrected for ties. 
 
Total headache frequency 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_cohort 13 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   TOTAL_MIG_FREQ_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 564.095a 2 282.047 28.697 .000 
Intercept .690 1 .690 .070 .793 
TOTAL_MIG_FREQ_0 519.786 1 519.786 52.885 .000 
COHORT 39.101 1 39.101 3.978 .056 
Error 265.372 27 9.829   
Total 2502.000 30    
Corrected Total 829.467 29    
a. R Squared = .680 (Adjusted R Squared = .656) 
 
Total Number of medication free days 
 
Between-Subjects Factors 
 Value Label N 
Cohort 1 Intervention_ 
cohort 
13 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   NO_MEDS2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 420.641a 2 210.321 16.686 .000 
Intercept 69.012 1 69.012 5.475 .027 
NO_MEDS0 370.426 1 370.426 29.388 .000 
COHORT 64.527 1 64.527 5.119 .032 
Error 340.326 27 12.605   
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Total 2861.000 30    
Corrected Total 760.967 29    
a. R Squared = .553 (Adjusted R Squared = .520) 
 
Total number of medication free days Mann Whitney test 
 
Ranks 
 Cohort N Mean Rank Sum of Ranks 
MED0M2 Intervention_cohort 13 10.54 137.00 
Control_cohort 17 19.29 328.00 





Mann-Whitney U 46.000 
Wilcoxon W 199.000 
Z -2.796 
Asymp. Sig. (2-tailed) .005 
Exact Sig. [2*(1-tailed Sig.)] .006b 
a. Grouping Variable: Cohort 




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASS_DEP_TOTAL_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1458.167a 2 729.084 13.405 .000 
Intercept 67.323 1 67.323 1.238 .275 
DASS_DEP_TOT_0 1458.150 1 1458.150 26.809 .000 
COHORT 2.570 1 2.570 .047 .829 
Error 1577.333 29 54.391   
Total 6000.000 32    
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Corrected Total 3035.500 31    




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASS_ANX_TOTAL_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 953.462a 2 476.731 15.490 .000 
Intercept 19.193 1 19.193 .624 .436 
DASS_ANX_TOT_0 943.854 1 943.854 30.667 .000 
COHORT 96.218 1 96.218 3.126 .088 
Error 892.538 29 30.777   
Total 3528.000 32    
Corrected Total 1846.000 31    




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
Tests of Between-Subjects Effects 
Dependent Variable:   DASSFULL2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 6884.750a 2 3442.375 9.739 .001 
Intercept 540.739 1 540.739 1.530 .226 
DASSFULL0 6754.738 1 6754.738 19.111 .000 
COHORT 393.537 1 393.537 1.113 .300 
Error 10250.125 29 353.453   
Total 47516.000 32    
Corrected Total 17134.875 31    
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 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   WEM_TOT_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 2245.807a 2 1122.903 16.462 .000 
Intercept 49.046 1 49.046 .719 .403 
WEM_TOT_0 2221.101 1 2221.101 32.561 .000 
COHORT 49.480 1 49.480 .725 .401 
Error 1978.162 29 68.212   
Total 70381.000 32    
Corrected Total 4223.969 31    




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   HMSE_TOTAL_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1734.240a 2 867.120 8.159 .002 
Intercept 231.217 1 231.217 2.176 .151 
HMSE_TOTAL_0 1732.563 1 1732.563 16.303 .000 
COHORT .352 1 .352 .003 .954 
Error 3081.978 29 106.275   
Total 372255.000 32    
154 
 
Corrected Total 4816.219 31    




 Value Label N 
Cohort 1 Intervention_cohort 15 
2 Control_cohort 17 
 
 
Tests of Between-Subjects Effects 
Dependent Variable:   ILC_TOTAL_2   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1725.205a 2 862.603 68.786 .000 
Intercept 163.026 1 163.026 13.000 .001 
ILC_0 1713.123 1 1713.123 136.609 .000 
COHORT .018 1 .018 .001 .970 
Error 363.670 29 12.540   
Total 46342.000 32    
Corrected Total 2088.875 31    












Appendix L: Mediation and moderation effects 
Mediation by changes in expectancy 
Sample 







          R       R-sq        MSE          F        df1        df2          p 
      .1948      .0379    23.6371      .5323     2.0000    27.0000      .5933 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant     3.2794     3.1130     1.0534      .3015    -3.1082     9.6669 
COHORT      -1.6252     1.7913     -.9073      .3723    -5.3007     2.0503 
AVDAYM_0      .8350     1.6964      .4922      .6265    -2.6458     4.3158 
 
Standardized coefficients 
              coeff 
COHORT       -.3398 







          R       R-sq        MSE          F        df1        df2          p 
      .8409      .7072      .0937    20.9309     3.0000    26.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant     -.3981      .2000    -1.9910      .0571     -.8092      .0129 
COHORT        .2342      .1145     2.0458      .0510     -.0011      .4695 
EXP_T1M0     -.0008      .0121     -.0696      .9451     -.0257      .0241 
AVDAYM_0      .8168      .1073     7.6142      .0000      .5963     1.0373 
 
Standardized coefficients 
              coeff 
COHORT        .4373 
EXP_T1M0     -.0075 
AVDAYM_0      .8117 
 





          R       R-sq        MSE          F        df1        df2          p 
      .8409      .7071      .0902    32.5953     2.0000    27.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant     -.4009      .1923    -2.0844      .0467     -.7955     -.0062 
COHORT        .2356      .1107     2.1284      .0426      .0085      .4626 
AVDAYM_0      .8161      .1048     7.7865      .0000      .6011     1.0312 
 
Standardized coefficients 
              coeff 
COHORT        .4398 
AVDAYM_0      .8110 
 
************** TOTAL, DIRECT, AND INDIRECT EFFECTS OF X ON Y ************** 
 
Total effect of X on Y 
     Effect         se          t          p       LLCI       ULCI       c_ps 
      .2356      .1107     2.1284      .0426      .0085      .4626      .4398 
 
Direct effect of X on Y 
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     Effect         se          t          p       LLCI       ULCI      c'_ps 
      .2342      .1145     2.0458      .0510     -.0011      .4695      .4373 
 
Indirect effect(s) of X on Y: 
             Effect     BootSE   BootLLCI   BootULCI 
EXP_T1M0      .0014      .0271     -.0636      .0472 
 
Partially standardized indirect effect(s) of X on Y: 
             Effect     BootSE   BootLLCI   BootULCI 






Attitudes to hypnosis 
Model  : 1 
    Y  : AVDAYM_2 
    X  : COHORT 
    W  : ATH_T_0 
 
Covariates:  AVDAYM_0 
 







          R       R-sq        MSE          F        df1        df2          p 
      .8575      .7352      .0881    17.3556     4.0000    25.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant     1.0760     1.8997      .5664      .5762    -2.8367     4.9886 
COHORT       -.2176     1.0474     -.2077      .8371    -2.3748     1.9396 
ATH_T_0      -.0328      .0409     -.8017      .4303     -.1170      .0514 
Int_1         .0103      .0222      .4612      .6486     -.0355      .0560 
AVDAYM_0      .8540      .1070     7.9792      .0000      .6336     1.0745 
 
Product terms key: 
 Int_1    :        COHORT   x        ATH_T_0 
 
Test(s) of highest order unconditional interaction(s): 
       R2-chng          F        df1        df2          p 





Model  : 1 
    Y  : AVDAYM_2 
    X  : COHORT 















          R       R-sq        MSE          F        df1        df2          p 
      .8421      .7091      .0968    15.2340     4.0000    25.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant     -.4590      .5051     -.9088      .3722    -1.4992      .5812 
COHORT        .3041      .3037     1.0011      .3264     -.3215      .9296 
EXPEC_0       .0114      .0888      .1280      .8992     -.1714      .1942 
Int_1        -.0134      .0552     -.2422      .8106     -.1271      .1003 
AVDAYM_0      .8158      .1110     7.3524      .0000      .5872     1.0443 
 
Product terms key: 
 Int_1    :        COHORT   x        EXPEC_0 
 
Test(s) of highest order unconditional interaction(s): 
       R2-chng          F        df1        df2          p 




Model  : 1 
    Y  : AVDAYM_2 
    X  : COHORT 













          R       R-sq        MSE          F        df1        df2          p 
      .8569      .7343      .0884    17.2759     4.0000    25.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant    -1.0629      .7087    -1.4997      .1462    -2.5226      .3968 
COHORT        .7960      .4377     1.8188      .0809     -.1054     1.6974 
TC__TOT0      .1021      .1111      .9188      .3670     -.1267      .3309 
Int_1        -.0862      .0679    -1.2704      .2156     -.2261      .0536 
AVDAYM_0      .8291      .1055     7.8595      .0000      .6118     1.0464 
 
Product terms key: 
 Int_1    :        COHORT   x        TC__TOT0 
 
Test(s) of highest order unconditional interaction(s): 
       R2-chng          F        df1        df2          p 
X*W      .0171     1.6139     1.0000    25.0000      .2156 
 
*********************** ANALYSIS NOTES AND ERRORS ************************ 
 
Level of confidence for all confidence intervals in output: 









Appendix M: Feedback summary to participants 
 
Thank you very much for your interest in the hypnosis for migraine and tension-type headaches study. 
Development 
The hypnosis intervention was developed by the lead researcher in consultation with project 
supervisors and feedback from migraine experiencers. 
Study 
Participants were allocated into one of two groups at random. One group took part in the 
group hypnosis session, followed by self-hypnosis immediately. The other group were 
offered group hypnosis followed by self-hypnosis two months later. This helped us to know 
whether the hypnosis was effective in reducing migraine and tension-type headache 
symptoms. The study ran from December 2020 until February 2021. 
There has been little research into hypnosis for migraines and tension-type headaches over 
the last 25 years, and the study hoped to assess the potential value of hypnosis in this area.  
Content within the group hypnosis session covered general information about migraines and 
tension-type headaches, their theorised causes, and factors that may lead to their triggers, and 
how we may be able to respond to these helpfully. The group hypnosis session was followed 
by 14-days of self-hypnosis at home. 
Results 
Our analysis of the headache diaries showed that the hypnosis intervention had an overall 
effect of reducing migraine and tension-type headache symptoms for participants. We also 
saw that the hypnosis intervention led to an increased number of medication-free days 
experienced by participants.  
The feedback we received from participants varied. For some, it produced reduced symptoms 
and an increased sense of control in managing triggers and migraine and tension-type 
headache symptoms. For these people, this increased hope and optimism for a future of 
increased control, while for a smaller number, no change in symptoms were experienced. 
What does this tell us? 
We found that hypnosis may potentially help some people with migraines and tension-type 
headaches. However, to be certain of this, further research needs to be completed to hopefully 




APPENDIX N: Author guideline notes for the International Journal of Clinical and 
Experimental Hypnosis 
The International Journal of Clinical and Experimental Hypnosis covers topics relevant to the 
research-informed practice of experimental and clinical hypnosis. The journal’s emphasis is 
to cover empirical research, clinical trials evaluating hypnosis intervention efficacy, 
mechanisms of hypnosis and systematic reviews, meta-analysis, and theoretical papers within 
the field of hypnosis. 
As this journal requires a word count of 3,500, this thesis will be reduced in words 
accordingly. 














APPENDIX O: End of study letter to Ethics Panel 
Dear Salomons Ethics Committee, 
Re: A pilot randomised controlled trial of an intervention comprising a single online 
group hypnosis session followed by self-hypnosis for migraines and tension-type 
headaches 
Study 
Participants with diagnoses of migraine or tension-type headache (N=35) were randomised 
into a waitlist-control (N=18) or intervention group (N=17). The intervention group took part 
in a single online group hypnosis session, followed by 14-days of self-hypnosis. The waitlist-
control group were offered group hypnosis followed by self-hypnosis two-months later upon 
study-completion. The study ran from December 2020 until February 2021. 
There has been little research into hypnosis for migraines and tension-type headaches over 
the last 25-years, and the study hoped to re-assess the potential value of hypnosis in this area.  
Content within the group hypnosis session covered general information about migraines and 
tension-type headaches, their theorised causes, and factors that may lead to their triggers and 
how people may be able to respond to these helpfully via methods that emphasised self-
empowerment. The group hypnosis session was followed by 14-days of self-hypnosis at 
home, which was a recording of the main group session. 
The primary hypothesis was that individuals in the intervention group would demonstrate 
significantly decreased migraine/tension-type headache mean daily headache ratings at post-
intervention. Secondary hypotheses included: the primary hypothesis would also be 
significantly different between groups at four-week follow-up, intervention participants 
would demonstrate significantly increased medication-free-days at both time-points, 
decreased anxiety, depression, and total DASS scores, increased well-being, internal-locus-
of-control and self-efficacy. Additionally, it was hypothesised that these outcomes would be 
moderated by expectancy, attitudes to hypnosis, suggestibility and mediated by post-
intervention changes in expectancy. 
Results 
Our analysis of the headache diaries showed that the hypnosis intervention group 
demonstrated a non-significant trend towards lowered mean daily headache ratings at post-
intervention, which was subsequently significantly different at four-week follow-up. This 
suggested at follow-up, the intervention had an overall effect of reducing migraine and 
tension-type headache symptoms for participants who received the hypnosis intervention at 
this time-point. We also saw that the hypnosis intervention led to an increase in the number 
of medication-free days experienced by participants and that there were non-significant 
trends towards reduced anxiety and frequency of migraine/tension-type headache symptoms, 
all at four-week follow-up. All other secondary measures and hypothesised moderators and 
mediators were non-significantly different at both time-points. 
The feedback we received from participants varied. For some, it produced reduced symptoms 
and an increased sense of control in managing triggers and migraine and tension-type 
headache symptoms. For them, this increased hope and optimism for a future of increased 
161 
 
control, while for a smaller number, no change in symptoms were experienced. One 
respondent provided a powerful response: “I do feel different. I have never done anything 
like this before. I feel more in control after a decade. I control the early onset of the pain 
which in turn does not develop into an attack. I would not have thought it was possible” 
All participants reported no significant harm or distress from the intervention. One participant 
in the control group during hypnosis (after the trial-end), reported racing thoughts. This 
appeared to be temporary and was managed by the second group-facilitator. The participant 
was contacted the next day and did not report any lasting effects. 
What does this tell us? 
We found that hypnosis may potentially help some people with migraines and tension-type 
headaches, in particular reducing their symptoms. However, to be certain of this, further 
research needs to be completed to hopefully repeat these findings with a larger group of 
people. The present study provides effect sizes, with which a more fully powered RCT can be 
designed. 
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